Ricerca

Categorie selezionate:   Europe & UK
Risultati

WHO Director-General's remarks at the Emergency Meeting of the United Nations Security Council – 10 November 2023

Leading Laboratories through Emergencies

Communicable disease threats report, 5 - 11 November 2023, week 45

EPI-WIN webinar: Preventing epidemics and pandemics through One Health in practice - Voices from One Health professionals

ECDC and WHO launch new surveillance tool for respiratory viruses to improve early detection

Communicable disease threats report, 15-22 October 2023, week 42

Communicable disease threats report, 24-30 September 2023, week 39

Top donor Germany signs major contribution to WHO for health emergencies; signs host agreement for WHO pandemic hub

WHO EPI-WIN webinar: Ready to respond to an outbreak of Ebola or Marburg disease - what's new in WHO Infection Prevention and Control guidelines?

Measles and rubella vaccine arrives in Kyrgyzstan to help stop measles outbreak

WHO launches toolkit for schools to create a tobacco- and nicotine-free environment

We must work together to protect future generations from the impacts of pandemic: UK statement at the UN Pandemic Prevention, Preparedness and Response High-level Meeting

WHO welcomes historic commitment by world leaders for greater collaboration, governance and investment to prevent, prepare for and respond to future pandemics

Multi-country outbreak of cholera, External situation report #8 - 2 November 2023

Seventh meeting of the Intergovernmental Negotiating Body (INB) for a WHO instrument on pandemic prevention, preparedness and response

FAO, WHO, and WOAH launch new online course on joint response to zoonotic disease outbreaks

UKHSA strategic plan 2023 to 2026: executive summary

New analysis confirms world seeing an upsurge of cholera

WHO releases step by step guide to help countries develop their national genomic surveillance strategy for pathogens with pandemic and epidemic potential

Polio outbreak in Ukraine closed – a success story for public health despite extreme challenges of war

Annual meeting of ECDC's National Focal Points (NFP) for Preparedness and Response, and for Threat detection, EWRS and IHR

Multi-country outbreak of mpox, External situation report#28 – 19 September 2023

Annual meeting of Strategic & Technical Advisory Group on Infectious Hazards with Pandemic and Epidemic Potential (STAG-IH) - 2023

Global Research and Innovations Forum: Building the world's resilience against future outbreaks and pandemics

Workshop on social and behavioural sciences for preparedness and response to infectious disease outbreaks

Legionellosis - Poland

Influenza A (H1N1) variant virus - the Netherlands

ECDC publishes epidemiological update on increased COVID-19 transmission, SARS-CoV-2 variants, and public health considerations for autumn 2023

Epidemiological update: COVID-19 transmission in the EU/EEA, SARS-CoV-2 variants, and public health considerations for Autumn 2023

About Influenza Division | CDC

Communicable disease threats report, 8-14 October 2023, week 41

WHO announces the release of ScreenTB - a web-based tool to help countries prioritize action for TB screening and prevention

A roadmap to combat postpartum haemorrhage between 2023 and 2030

Ending the COVID-19 emergency and transitioning from emergency phase to longer-term disease management: guidance on calibrating the response, 4 September 2023

Bringing hope to communities: WHO installs new module clinic for primary health care in Kharkiv region

West Nile virus - human cases, 12 July 2023

Influenza A(H5N1) in cats – Poland

Epidemiological update: Echovirus 11 infections in neonates

Pandemic Influenza Preparedness (PIP) Framework

Africa CDC, WHO and RKI Launch a Health Security Partnership to Strengthen Disease Surveillance in Africa

Spread of multidrug-resistant Shigella in EU/EEA among gay, bisexual and other men who have sex with men

Communicable disease threats report, 1-7 October 2023, week 40

Vulnerable? Vaccinate. Protecting the unprotected from COVID-19 and influenza

Public health and emergency workforce roadmap steering committee endorses tools, commits to action in Rome - ISS

Communicable disease threats report, 9-15 July 2023, week 28

Recognition of Bhutan's National Reference Laboratory as a National Influenza Centre in the WHO Global Influenza Surveillance and Response System.

Welcoming a new era for respiratory pathogen pandemic preparedness in the Western Balkans and the Republic of Moldova

West Nile virus - infections among humans and outbreaks among equids and/or birds, 12 July 2023

West Nile virus - human cases compared to previous seasons, 12 July 2023

London at risk of measles outbreaks with modelling estimating tens of thousands of cases

Weekly epidemiological update on COVID-19 - 13 July 2023

Bringing mpox vaccination, health advice and care closer to people living with HIV in France: spotlight on the work of AIDES

Diagnostics laboratory emergency use listing

Donors making a difference: building stronger health systems

Public health and emergency workforce roadmap

Zika virus disease

Treating malaria

Air pollution: The invisible health threat

Recommended package of interventions for HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for people in prisons and other closed settings

MMWR Weekly COVID-19 Briefing

Ebola and Marburg diseases screening and treatment center design

WHO public report for the kit performance evaluation of YF MAC-HD 1.0 assay to detect IgM to yellow fever virus in the context of surveillance

Strengthening rehabilitation in health emergency preparedness, readiness, response and resilience: policy brief

Enterovirus-Echovirus 11 Infection - the European Region

Communicable disease threats report, 2-8 July 2023, week 27

Announcing the Release Candidate of WHO Digital Open Rule Integrated cause of death Selection (DORIS) tool

Seasonal influenza - Annual Epidemiological Report for 2022/2023

Influenza Risk Assessment Tool (IRAT) | Pandemic Influenza (Flu) | CDC

Multi-country outbreak of cholera, External situation report #4 - 6 July 2023

One year of health emergency support in Ukraine: WHO Ukraine launches its annual report

Introducing rapid social listening and infodemic insights for action: WHO and UNICEF launch manual on 6 steps to build an infodemic insights report

Advancing the global agenda on prevention and control of noncommunicable diseases 2000 to 2020: looking forwards to 2030

18 million doses of first-ever malaria vaccine allocated to 12 African countries for 2023–2025: Gavi, WHO and UNICEF

All secondary school pupils eligible for free flu vaccine

WHO/Europe releases new software to support country assessment of the health benefits of policies to mitigate climate change

WHO EPI-WIN webinar: Getting PRET for the next pandemic: national and regional experiences

Surveillance of influenza and other seasonal respiratory viruses in the UK

Pilot protocol for influenza vaccine effectiveness against laboratory-confirmed influenza infections (symptomatic) using healthcare worker cohorts

Legionnaires' disease - Annual Epidemiological Report for 2021

WHO EPI-WIN webinar: Strengthening One Health operations in countries for improved preparedness to emerging zoonotic diseases

Tuberculosis (TB): migrant health guide

CDC's Building Resilience Against Climate Effects (BRACE) Framework | CDC

Novel vaccines may help quell polio outbreaks

Statement – 36 million people across the European Region may have developed long COVID over the first 3 years of the pandemic

WHO's response to health emergencies: annual report 2022

Public health operational guidelines for typhoid and paratyphoid (enteric fever) - version 1 - Public health operational guidelines for typhoid and paratyphoid (enteric fever) - Publications - Public Health Scotland

Characteristics of Medical Evacuation by Train in Ukraine, 2022

Antimicrobial Resistance elearning Course - eIntegrity

Water, sanitation and hygiene

New WHO AI tool invites people to counter online promotion of unhealthy products

WHO Partners Forum highlights importance of sustainable funding for tackling emergencies, climate change and better health for all

The One Health approach and Key Recommendations of the Quadripartite

Zika virus disease - Annual Epidemiological Report for 2021

Dengue - Annual Epidemiological Report for 2021

Chikungunya virus disease - Annual Epidemiological Report for 2021

Increasing risk of mosquito-borne diseases in EU/EEA following spread of Aedes species

Sexual Health (HIV content only) elearning Course - eIntegrity

Global research agenda for antimicrobial resistance in human health

Dr Vanessa Kerry appointed as WHO Director-General Special Envoy for Climate Change and Health

World No Tobacco Day 2023 Awards - Celebrating Remarkable Achievements for Thailand

Tuberculosis guideline - version 1 - Tuberculosis guideline - Publications - Public Health Scotland

Early success in health system recovery in Ukraine, new WHO report highlights

New good practice statement on counselling behavioural interventions for key populations to prevent HIV, viral hepatitis and STIs

Maternal and Neonatal Deterioration - elearning for healthcare

Screening newborns for deadly immune disease saves lives

WHO EPI-WIN webinar: Global mpox strategy for elimination and control: open consultation

Systematic screening for tuberculosis disease

HPV vaccination programme moves to single dose from September 2023

Building resilient systems where health and justice meet

Over six million disabled people start receiving £150 Cost of Living payment

Clinical practice handbook for quality abortion care

Lessons From COVID-19 for Protecting Workers in the Next Pandemic

Countries set out way forward for continued negotiations on global agreement on pandemic prevention, preparedness, and response

Health and Climate Change Global Survey

Core Anaesthesia Training : eIntegrity eLearning Courses

WHO/Europe explores collaborations to improve quality of health information online

World Refugee Day 2023 in the WHO European Region: health inclusion and solutions for refugees and host communities

Small islands agree bold plan of action on health and climate crises

Contingency Fund for Emergencies: 2022 annual report: enabling quick action

Clearing the air – the introduction of Glasgow's Low Emission Zone (LEZ) - Our blog - Public Health Scotland

Dracunculiasis (Guinea-worm disease)

Government takes action to strengthen local care systems

About HIV/AIDS | HIV Basics | HIV/AIDS | CDC

Cross-border cooperation in subnational settings discussed at the 17th Public Health World Congress in Rome

Candida auris: update to management guidance

Guidance on Operational Microplanning for COVID-19 Vaccination

Training to build community capacity to meaningfully engage in mpox response

Monthly operational update on health emergencies - May 2023

WHO steps up its humanitarian response in southern Ukraine following the destruction of the Kakhovka Dam

WHO/Europe releases a toolbox to protect children's health from chemical pollution of indoor air in schools and day-care centres

Frontline health facilities faltering without water, sanitation, hygiene and electricity – WHO, UNICEF new report

Environment, climate change and health for practitioners and actors guiding policy change

With the international public health emergency ending, WHO/Europe launches its transition plan for COVID-19

Dowden: world-class crisis capabilities deployed to defeat biological threats of tomorrow

Antiviral treatment for avian influenza

Toward a deeper understanding of long COVID

Surveillance to Track Progress Toward Polio Eradication — ...

Epidemic Intelligence, the italian experts join the new Who platform - ISS

Protective measures and options for public health response for avian influenza

The DURABLE project against epidemics - ISS

Investigating Unexplained Respiratory Outbreaks (URDO) | CDC

Simulation Exercises and emergency preparedness: An interview with Dr Muhammed Al Azebi

England on track to end new HIV transmissions by 2030

NAM President Victor Dzau Emphasizes Sustainable Regional Vaccine Manufacturing for Global Health Security - National Academy of Medicine

Assessment of polio outbreak response in Ukraine brings country major step closer to official closure of the outbreak

11 smallest countries in WHO European Region adopt landmark statement committing to key actions to improve people's health

ECDC-EMA statement on updating COVID-19 vaccines composition for new SARS-CoV-2 virus variants

A New Antiviral Option for CMV Prevention After Kidney Transplant

United Kingdom: Partners in global health

Insights from Malawi's Deep Dive of the Integrated Disease Surveillance System | IANPHI | Atlanta GA

WHO and the UK hone their collaboration against pandemics, other health threats

Emerging diseases: DURABLE, a European project led by the Institut Pasteur

Launch of consultative process towards REACH 2035 Agenda: Research for Action on Climate Change and Health

Global Digital Health Certification Network

SB58 Bonn Climate Change Conference side event: Integrating Health into the Global Stocktake​

The European Commission and WHO launch landmark digital health initiative to strengthen global health security

Developing a global research agenda for public health and social measures: Research priorities for COVID-19

Epidemiological repository on particulate matter and mortality

Interim Guidance for Clinicians on Human Infections with Variant Flu

HAIRS risk assessment: avian influenza A(H5N1) in non-avian UK wildlife

Investigation into the risk to human health of avian influenza (influenza A H5N1) in England: technical briefing 4

Webinar: Whole genome sequencing as a tool to strengthen foodborne disease surveillance and response

Heat mortality monitoring report: 2022

Tetanus in England: 2022

CDC's Mpox Large Gatherings and Social Events Toolkit

Covid-19: WHO treaty on future pandemics is being watered down, warn health leaders

WHO Malaria Policy Advisory Group (MPAG) meeting

Avian Influenza A(H5N1) - United Kingdom of Great Britain and Northern Ireland

Third WHO consultation on the translation of tuberculosis research into global policy guidelines: meeting report, 4 April 2023

Professional Clinical Midwifery Leadership elearning Course - eIntegrity

Variants of the Virus COVID-19 Data Monitoring the impact of COVID-19 and

EPI-WIN webinar: Emerging Zoonotic diseases and the One Health approach

WHO releases data.who.int

Strengthening influenza preparedness through an OpenWHO online course

National tuberculosis prevalence surveys: what diagnostic algorithms should be used in future?

WHO launches global network to detect and prevent infectious disease threats

Global strategic preparedness, readiness and response plan for cholera

WHO announces the development of the Consolidated Guidelines on STI prevention and care (2022-2023)

EPI-WIN webinar: MERS-CoV, a circulating coronavirus with epidemic and pandemic potential - Pandemic preparedness, prevention and response with a One Health approach

New WHO report highlights progress, but also remaining gaps, in ensuring a robust pipeline of antibiotic treatments to combat antimicrobial resistance (AMR)

Multi-country outbreak of cholera, External situation report #2 - 11 May 2023

Progress Toward Poliomyelitis ...

Infodemic management: Developing an infodemic insights report

Multi-country outbreak of mpox, External situation report #22 - 11 May 2023

Climate and Health Youth Education Toolkit

Monthly operational update on health emergencies - April 2023

Covid-19: WHO declares end of global health emergency

Cross-border response to Ebola at points of entry: difficult but possible with rapid response

NIH study identifies features of Long COVID neurological symptoms

Communicable disease threats report, 30 April - 6 May 2023, week 18

Introduction to virology, diagnostics and molecular epidemiology on emerging and vector-borne disease viral pathogens

Cholera worldwide overview

Guidance on operational microplanning for COVID-19 vaccination, revised 2 May 2023

ECDC presents lessons learned from the COVID-19 pandemic

Surveillance Atlas of Infectious Diseases

Communicable disease threats report, 23-29 April 2023, week 17

The Building Resilience Against Climate Effects framework

Webinar: The WHO AWaRe antibiotic book - what it is and how to use it

Measles - Annual Epidemiological Report for 2022

Communicable disease threats report, 16-22 April 2023, Week 16

WHO consolidated guidelines on tuberculosis: Module 1: Prevention - infection prevention and control

Global Compendium of Knowledge on COVID-19

Influenza Update N° 443

TB Joint External Monitoring Mission (JEMM) Report, 2022

Guidance on regulations for the transport of infectious substances 2021-2022

Quadripartite One Health Intelligence Scoping Study

EPI-WIN webinar: Managing plague in the field

Communicable disease threats report, Week 15, 9-15 April 2023

Public health considerations for mpox in EU/EEA countries

Antimicrobial resistance surveillance in Europe - 2023

COVID-19 Vaccine Insights Report - 11 April 2023

Influenza Update N° 442

Vector control products targeting outdoor malaria transmission: preferred product characteristics

Tick-borne encephalitis detection in England

Autumn vaccination campaigns focused on older age groups and other high-risk populations are key to decrease impact of COVID-19

Strengthening infectious disease control in Ukraine

Long-term surveillance framework 2021–2027

The role of communities in cholera vaccination campaigns

Malaria incident cases per 1000 persons per year (SDG 3.3.3)

Communicable disease threats report, Week 13, 26 March - 1 April 2023

Listeriosis - Annual Epidemiological Report for 2020

Influenza virus characterization - Summary Europe, February 2023

Advance Your One Health Skills - OHWA Training

Drugs to prevent COVID-19: living guideline

WHO Tools for strengthening emergency care systems

Health Emergency Preparedness, Response and Resilience

The health workforce crisis in Europe is no longer a looming threat – it is here and now. The Bucharest Declaration charts a way forward

Emergence of extensively drug-resistant Shigella sonnei strain in France

Conducting after-action reviews of the public health response to COVID-19

Pandemic Preparedness, Alert, and Response | June 12-14, 2023

Crimean-Congo haemorrhagic fever - Annual Epidemiological Report for 2020

Communicable disease threats report, Week 11, 12-18 March 2023

Zika virus disease - Annual Epidemiological Report for 2020

Dengue and severe dengue

The role of communities in case management and surveillance for cholera outbreaks

WHO signs partnership agreement with MapAction

Epidemiology and diagnostic testing for Leptospirosis, an emerging public health problem

EPI-WIN webinar: Influenza – avian influenza H5: its evolution and associated risk

WHO publishes recommendations on two new types of insecticide-treated nets

Regional workshop on COVID-19 recovery in Tunisia

WHO's response to the Ukraine crisis: annual report, 2022

WHO Webinar Series on Trust and Pandemic Preparedness

Influenza Update N° 440

Environmental cleaning and infection prevention and control in health care facilities in low- and middle-income countries

The European Union Summary Report on Antimicrobial Resistance in zoonotic and indicator bacteria from humans, animals and food in 2020/2021

Variant Creutzfeldt−Jakob disease - Annual Epidemiological Report for 2020

Sustainable preparedness for health security and resilience

Global climate change:

Communicable disease threats report, week 9, 27 February - 5 March 2023

Polio dashboard

EPI-WIN webinar: Cholera outbreaks: The current situation and what are doing to address it

Recommendations announced for influenza vaccine composition for the 2023-2024 northern hemisphere influenza season

Multi-country outbreak of mpox, External Situation report # 17 - 2 March 2023

Navigating Infodemics and Building Trust during Public Health Emergencies: A Workshop

Cluster of avian influenza in Cambodia

Vector control operations framework for Zika virus

Guidelines for the clinical management of severe illness from influenza virus infections

WHO Ukraine crisis response: January 2023 bulletin

Working with communities to strengthen WASH in cholera outbreaks

EPI-WIN webinars, World Health Organization's information network for epidemics webinars on COVID-19

First-of-its-kind WHO/Europe course puts health workforce and leadership at the heart of health system recovery

WHO Health and Climate Change Global Survey

EPI-WIN webinar: Influenza vaccines: what makes them work

Mpox: Clinicians identify severe form with high mortality in advanced HIV patients

Influenza Update N° 439

Communicable disease threats report, week 7, 12-18 February 2023

ECDC hosts refresher training on epidemic intelligence

Guiding principles for pathogen genome data sharing and lessons learned during public health emergencies

WHO Global Clinical Data Platform for the clinical characterization of Ebola: Statistical analysis plan, 17 February 2023

WHO EPI-WIN webinar: Changing perspectives of the mpox outbreak

H5N1: Do we need to worry about the latest bird flu outbreaks?

Methodological principles of nationally representative surveys as a platform for global surveillance of antimicrobial resistance in human bloodstream infections

NIH RECOVER research identifies potential long COVID disparities

Covid-19: Evusheld is unlikely to prevent infection with current or future variants, NICE concludes

Health as a Lever for Action on Climate Change: Conference Highlights | IANPHI | Atlanta GA

Webinar: WHO costing & budgeting tool for national action plans on AMR - A review and country experiences

Protocol for point prevalence surveys of healthcare-associated infections and antimicrobial use in European long-term care facilities – version 4.0

As the mpox "emergency" continues, the United Kingdom shows how achieving and sustaining disease elimination has to be the next priority

NIH trial to evaluate Shionogi antiviral in adults hospitalized with COVID-19

Review of recent emerging and re-emerging virus outbreaks

Lingering symptoms common after COVID hospitalization

Covid-19: WHO treaty hopes to overcome "catastrophic failures" of pandemic response

Member States guide direction of polio transition post-2023

Adaptation and implementation of WHO's multisectoral accountability framework to end TB (‎MAF-TB)‎: best practices

Cholera – Global situation

WHO in collaboration with IATA have trained trainers on the shipping of infectious substances

Immediate and targeted catch-up vaccination needed to avert measles resurgence

Influenza Update N° 438

Global clinical data platform: Cholera case report form (‎CRF)‎: module 3

Human monkeypox: diagnosis and management

Protecting infants through covid-19 vaccination during pregnancy

Gastrointestinal and Zoonoses - Biennial report 2020 to 2021 - Gastrointestinal and Zoonoses - Publications - Public Health Scotland

WHO EPI-WIN webinar: Current COVID-19 situation and what's next for COVID-19

Multi-country outbreak of mpox, External situation report#15- 2 February 2023

Statement of the thirty-fourth Polio IHR Emergency Committee

International Pandemic Preparedness Secretariat Releases New Report; NAM President Victor Dzau Co-Chairs IPPS Scientific Advisory Group - National Academy of Medicine

Launch of global individual patient data platform for tuberculosis treatment

Global report on neglected tropical diseases 2023

Core protocol for ECDC studies of COVID-19 vaccine effectiveness against hospitalisation with Severe Acute Respiratory Infection, laboratory-confirmed with SARS-CoV-2 or with seasonal influenza - Version 2.0

Protocol for a COVID-19 vaccine effectiveness study using health data registries

Point prevalence survey of healthcare-associated infections and antimicrobial use in European long-term care facilities 2016–2017

Update 83: The Global Influenza Outbreak - What we are doing and what it means for pandemic influenza

Three years of pandemic learning response: reaching learners across the world with life-saving health knowledge

Webinar – Launch of the new publication "National Stockpiles for Radiological and Nuclear Emergencies: Policy Advice"

Influenza Update N° 437

WHO Webinar Series on Trust and Pandemic Preparedness

WHO EPI-WIN webinar: Current COVID-19 situation and what's next for COVID-19

Practical manual on tuberculosis laboratory strengthening updated to support the implementation of WHO-recommended diagnostics

Covid-19: Vaccination plus infection offers best protection, finds study led by WHO

Influenza virus characterization - Summary Europe, December 2022

Outbreak and Crisis Response Appeal 2023

Joint FAO/WHO Expert Meeting on the pre- and post-harvest control of Campylobacter spp. in poultry meat

Practical manual on tuberculosis laboratory strengthening, 2022 update

WHO Webinar Series on Trust and Pandemic Preparedness: Webinar 1: Trust and pandemics

Covid-19: What do we know about XBB.1.5 and should we be worried?

WHO Policy Brief: Gatherings in the context of COVID-19, 19 January 2023

Public health management of possible cases - COVID-19 - guidance for health protection teams (HPTs) - version 2.6 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland

Operational manual on leishmaniasis vector control, surveillance, monitoring and evaluation

COVID-19 Symptoms 6 Months After Onset and the Role of Vaccination for SARS-CoV-2 Infection

Experimental HIV vaccine regimen safe but ineffective, study finds

8th WHO Technical Taskforce: Defeating Meningitis by 2030 – A Global Road Map

How are covid-19 symptoms changing?

Most long covid effects resolve within a year after mild infection | BMJ

Introduction - COVID-19 - guidance for health protection teams (HPTs) - version 2.6 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland

Contacts of confirmed cases of COVID-19 - COVID-19 - guidance for health protection teams (HPTs) - version 2.6 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland

Management of COVID-19 outbreaks - COVID-19 - guidance for health protection teams (HPTs) - version 2.6 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland

Checklist for COVID-19 outbreaks - COVID-19 - guidance for health protection teams (HPTs) - version 2.6 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland

Vaccination - COVID-19 - guidance for health protection teams (HPTs) - version 2.6 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland

COVID-19 PCR testing network scaled down

WHO announces plans to establish a TB Vaccine Accelerator Council

Better recognition for research participants: what society should learn from covid-19

Guidance for Cleaning, Disinfection, and Waste Disposal in Commercial Passenger Aircraft | Cleaning and Decontamination | Public Health Planners | Ebola (Ebola Virus Disease) | CDC

Potential for improvement in governance and national action plans to overcome antimicrobial resistance

COVID-19 - guidance for health protection teams (HPTs) - version 2.6 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland

WHO/BS/2022.2426 Rev: A Collaborative Study to Evaluate the Proposed 1st WHO International Standard for SARS-CoV-2 Antigen

Webinar: WHO People centred framework on addressing AMR - Information session ahead of online global consultation

Global Measles Outbreaks

Solidarity Against Ebola/Tokomeza Ebola - A flipbook for discussion between the study team and potential study participants

Episode #90 - Influenza

Guide for clinicians evaluating an ill person for Ebola disease | Evaluating Patients | Clinicians | Ebola (Ebola Virus Disease) | CDC

WHO welcomes data on COVID-19 in China, meeting with Minister

Rapid recommendation: A living WHO guideline on drugs for covid-19

Call for Expression of Interest: Scoping review of Science and Knowledge Translation in health emergency policy-making

Botulism - Annual Epidemiological Report for 2020

Weekly influenza update, week 1, January 2023

WHO EPI-WIN Webinar: The current global influenza outbreak: what we are doing and what it means for pandemic influenza

Communicable disease threats report, 9-13 January 2023, week 2

E-learning: COVID-19 infodemic management: risk communication and community engagement challenges, by WHO

ECDC assesses risk to the EU/EEA associated with Omicron XBB1.5 sub-lineage

Threat Assessment Brief: Implications for the EU/EEA of the spread of the SARS-CoV-2 Omicron XBB.1.5 sub-lineage

WHO updates COVID-19 guidelines on masks, treatments and patient care

The generic all-hazards risk assessment and planning tool for mass gathering events

Pilot study outline for targeted genomic surveillance of SARS-CoV-2 in travellers in response to a worsening or unknown epidemiological situation in a third country

Infection prevention and controlin the context of coronavirus disease (COVID-19): A living guideline

Clinical management of COVID-19: Living guideline, 13 January 2023

Therapeutics and COVID-19: Living guideline, 13 January 2023

Safety and monitoring for patients receiving Nirmatrelvir-ritonavir for COVID-19

Administration of Nirmatrelvir-ritonavir for COVID-19

Nirmatrelvir-ritonavir for COVID-19

WHO Director-General's opening remarks at the second and final Principals' Meeting of the Joint Action Group to review the impact of the COVID-19 pandemic on the world's transport workers and the global supply chain (JAG-TSC) – 24 January 2023

Syndromic surveillance: weekly summaries for 2023

Online training on tuberculosis laboratory biosafety

Cholera Outbreak — Haiti, September 2022–January 2023

Developing mucosal vaccines for respiratory viruses

WHO Director-General's opening remarks at the media briefing – 11 January 2023

Ebola Recommendations for Organizations | Quarantine | CDC

Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 18 December 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland

Mpox prevention and control among people living in prison

Weekly national respiratory infection and COVID-19 statistical report 11 January 2023 - Weekly national respiratory infection and COVID-19 statistical report - Publications - Public Health Scotland

Latest data on respiratory infections in Scotland - News - Public Health Scotland

COVIDGuidance.org

EASA/ECDC provide guidelines for aviation as part of European response to COVID-19 developments in China

Guidelines in response to the worsening of the epidemiological situation - Addendum to the Aviation Health Safety Protocol

Mpox prevention and control in people visiting prison

Communicable disease threats to public health in the European Union - Annual Epidemiological Report for 2020

Paxlovid reduces serious risks from Omicron variants

Hantavirus infection - Annual Epidemiological Report for 2020

Monkeypox (mpox) - Conditions and diseases - Our areas of work - Public Health Scotland

Malaria - Annual Epidemiological Report 2020

UKHSA begins testing arrivals from China to enhance detection of new variants

Statement – Science, surveillance, responsibility: the essentials to addressing the ongoing COVID-19 challenge

Varicella vaccine (live): PGD template

Precautionary and temporary measures to improve COVID surveillance from China

NIH funds eight studies to advance rapid diagnosis of COVID-19-related inflammatory syndrome in children

EMRG medium-term projections for COVID-19 hospitalisations and deaths: 21 December 2022

Mpox - Clinical Quick Reference

Protecting the workforce through influenza and COVID-19 vaccination: perspectives from Greece

England and Wales see rise in excess deaths amid flu surge

Weekly national respiratory infection and COVID-19 statistical report 6 January 2023 - Weekly national respiratory infection and COVID-19 statistical report - Publications - Public Health Scotland

Advisory group urges countries to prioritize protecting the most vulnerable with COVID-19 vaccination and integrate COVID-19 vaccination into routine health-care strategies

About VSP Outbreak Investigations | VSP | CDC

Flu Vaccine Uptake in Caregivers and Noncaregivers: Implications for Policy and Practice

Mpox Cases Among Cisgender Women and Pregnant Persons — United States, May 11–November 7, 2022

Multi-country outbreak of mpox, External situation report #13 - 5 January 2023

Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 11 December 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland

Update on SARS-CoV-2 variants: ECDC assessment of the XBB.1.5 sub-lineage

About the Vessel Sanitation Program | VSP | CDC

Communicable disease threats report, 2-8 January 2023, week 1

Cholera Outbreaks: Emergency Preparedness and Response

NIH study links specific outdoor air pollutants to asthma attacks in urban children

WHO Director-General's opening remarks at the media briefing – 4 January 2023

TAG-VE statement on the 3rd January meeting on the COVID-19 situation in China

NOIDs causative agents: week 52 (week ending 1 January 2023)

COVID-19 vaccine for children after MIS-C appears safe

Covid-19: Doctors are asked to help track variants among people arriving from China

Impact of surge in China COVID-19 cases on epidemiological situation in EU/EEA

Back to school advice issued amid high levels of flu, COVID-19 and scarlet fever

Keeping Your Hands Clean on a Cruise | VSP | CDC

NOIDs causative agents: week 51 (week ending 25 December 2022)

The Mpox Vaccine (JYNNEOS Vaccine) | Monkeypox | Poxvirus | CDC

WHO meets with Chinese officials on current COVID-19 situation

Precautionary and temporary measures introduced to improve Covid surveillance from China

Simulation exercises

Information for Cruise Ship Travelers | VSP | CDC

Mpox in the U.S.

Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons — 29 U.S. Jurisdictions, May 22–September 3, 2022 | MMWR

Notes from the Field: Clinical and Epidemiologic Characteristics of Mpox Cases from the Initial Phase of the Outbreak — New York City, May 19–July 15, 2022 | MMWR

Coronavirus Test Device Approvals (CTDA): statutory review of process

Statutory review of the Coronavirus Test Device Approvals (CTDA) process

Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 04 December 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland

WHO trains thousands of health care workers in mass casualty and trauma care amid the war

Health workers in North Macedonia urge vulnerable people: get vaccinated against seasonal influenza

Training on handling, storing and transporting Pfizer-BioNTech COVID-19 mRNA Vaccine COMIRNATY® (Tozinameran)

HIV prevention, diagnosis and care for Ukrainian refugees in Poland

Sharing International Health Regulations information

Technical guidance

Case management

EMRG medium-term projections for COVID-19 hospitalisations and deaths: 7 December 2022

Malaria vaccine implementation programme

Conducting International Health Regulations simulation exercises

Mpox Strategic Preparedness, Readiness, and Response Plan: Global Monitoring and Evaluation Framework

COVID-19 Response Fund

COVID-19: UKHSA laboratory assessments of inactivation methods

Influenza Update N° 435

Scarlet fever infections rise to nearly 30 000, UKHSA reports

One Health Joint Plan of Action launched and presented by WHO and the Quadripartite partners

One Health in G20 countries

Covid-19: Molnupiravir does not cut hospital admissions or deaths in vaccinated people at high risk, trial finds

Gift yourself a life-saving vaccine this Christmas holiday

Surveillance, case investigation and contact tracing for Monkeypox: Interim guidance

Optimizing surveillance of antimicrobial consumption (AMC)

Communicable disease threats report, 18-24 December 2022, week 51

Do you take antibiotics only when prescribed by your doctor? A population-based survey in Armenia asks questions to raise awareness

Recommendations to better understand the origins of and factors for the emergence and re-emergence of mpox

Product Information Leaflet (PIL) for VidPrevtyn Beta dispersion for injection

Bridging the gap between ethics and decision-making in pandemics: report of the WHO Pandemic Ethics and Policy Summit, 6 December 2021

WHO Director-General's opening remarks at the media briefing – 21 December 2022

Weekly epidemiological update on COVID-19 - 21 December 2022

Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 27 November 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland

Regulatory approval of COVID-19 vaccine VidPrevtyn Beta

Weekly national respiratory infection and COVID-19 statistical report 21 December 2022 - Weekly national respiratory infection and COVID-19 statistical report - Publications - Public Health Scotland

Sanofi Pasteur COVID-19 vaccine authorised by MHRA

WHO Information Meeting on the Composition of Influenza Virus Vaccines for Use in the 2023-2024 Northern Hemisphere Influenza Season

COVID-19 surveillance and study protocols

World Chagas Disease Day 2022

Ambient (outdoor) air pollution

Diphtheria - Vaccine Preventable Diseases Surveillance Manual | CDC

WHO operational handbook on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update

Salmonellosis - Annual Epidemiological Report for 2021

Avian influenza overview September – December 2022

Listeriosis - Annual Epidemiological Report for 2021

Hepatitis A - Annual Epidemiological Report for 2021

STEC infection - Annual Epidemiological Report for 2021

Seasonal influenza 2021−2022 - Annual Epidemiological Report

Shigellosis - Annual Epidemiological Report for 2019

Campylobacteriosis - Annual Epidemiological Report for 2021

Yersiniosis - Annual Epidemiological Report for 2021

Ebola vaccine regimens safe, immunogenic in adults and children

North Macedonia's caravan: bringing COVID-19 vaccines and information about influenza and other vaccines to communities

Antiviral resistance monitoring capability and capacity for SARS-CoV-2 and influenza within the EU/EEA

Communicable disease threats report, 11 - 17 December 2022, week 50

Bird flu (avian influenza): findings in non-avian wildlife

Weekly influenza update, week 49, December 2022

The COVID-19 risk communication package for community members in various settings

Episode #88 - Living with COVID-19

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States, September 8–November 30, 2022

Infectious diseases in asylum seekers: actions for health professionals

Mask and outbreak guidance updated in care settings

Prevalence of SARS-CoV-2 and Influenza Coinfection and Clinical Characteristics Among Children and Adolescents Aged <18 Years Who Were Hospitalized or Died with Influenza — United States, 2021–22 Influenza Season

How Flu Viruses Can Change

ECDC expert consultation on the implementation and evaluation of non-pharmaceutical interventions

Evaluation of medicines to prevent COVID-19

Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 20 November 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland

Weekly national respiratory infection and COVID-19 statistical report 14 December 2022 - Weekly national respiratory infection and COVID-19 statistical report - Publications - Public Health Scotland

South-East Asia stakeholder forum for pandemic influenza preparedness

Monkeypox in the U.S.: Pets in the Home

EMFLU 2.0: improved flu data sharing in the Eastern Mediterranean

Steps in a Multistate Foodborne Outbreak Investigation

US & UK National Medical Academies Commit to Action on Climate Change & Call for Action by World Health Leaders - National Academy of Medicine

Control measures for Shiga toxin-producing Escherichia coli (‎STEC)‎ associated with meat and dairy products: meeting report

ECDC organises epidemic intelligence and rapid risk assessment training in Armenia

Zoonotic diseases and foodborne outbreaks on the rise, but still below pre-pandemic levels

Pneumococcal disease infections caused by serotypes not in Prevenar 13 vaccine

Strengthening national legislation around the International Health Regulations (IHR)

Episode #14 - COVID-19 - Tests

Risk of severe pressure on healthcare systems due to RSV, flu and COVID-19 co-circulation

Intensified circulation of respiratory syncytial virus (RSV) and associated hospital burden in the EU/EEA

Middle East respiratory syndrome coronavirus (MERS-CoV)

Annual Epidemiological Reports (AERs)

Last updated 12/2022 - Summary of Product Characteristics Comirnaty 3 micrograms/dose concentrate for ages 6 months to 4 years (maroon cap)

Weekly influenza update, week 48, December 2022

Covid-19: Winter surge feared as China lurches away from zero covid

Ukraine endorses roadmap on mental health during the war

ECDC and EMA collaborate on vaccine safety and effectiveness monitoring studies

Communicable disease threats report, 4 – 10 December 2022, week 49

Moving WHO guidance on antibiotics into the heart of clinical practice

Rehabilitating contaminated sites

WHO member states agree to draft international pandemic accord

Report signals increasing resistance to antibiotics in bacterial infections in humans and need for better data

Global antimicrobial resistance and use surveillance system (‎GLASS)‎ report: 2022

Episode #87 - Is Measles making a comeback

Mpox Toolkit for Correctional and Detention Facilities

Human Rabies — Texas, 2021

Safety Monitoring of JYNNEOS Vaccine During the 2022 Mpox Outbreak — United States, May 22–October 21, 2022

Progress Toward Poliomyelitis Eradication ― Afghanistan, January 2021–September 2022

Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022

The European Union and WHO further enhance their partnership for stronger pandemic preparedness and response

Chikungunya fact sheet

Ebola disease caused by Sudan ebolavirus – Uganda

Climate change

Zika virus

World malaria report 2022

UKHSA publishes strategy outlining plans to eliminate mpox transmission

Despite continued impact of COVID-19, malaria cases and deaths remained stable in 2021

WHO trains hundreds of health-care workers to reduce number of health-care associated infections in Ukraine

Data on mpox (monkeypox) cases in the EU/EEA

Weekly national respiratory infection and COVID-19 statistical report 7 December 2022 - Weekly national respiratory infection and COVID-19 statistical report - Publications - Public Health Scotland

Mpox (Monkeypox)

Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 13 November 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland

In Denmark, people roll up their sleeves for seasonal influenza and COVID-19 vaccines

Influenza Virus Genome Sequencing and Genetic Characterization | CDC

Scottish COVID-19 Contact Tracing Programme - COVID-19 - Respiratory infections - Conditions and diseases - Our areas of work - Public Health Scotland

The WHO Global Clinical Platform for Ebola virus disease

Using mRNA technology for a universal flu vaccine

Experimental mRNA Vaccine May Protect Against All 20 Influenza Virus Subtypes

Message by the Director of the Department of Immunization, Vaccines and Biologicals at WHO - December 2022

Health-care associated infection surveillance

Outbreak investigations

Influenza virus characterization - Summary report, Europe, October 2022

Antimicrobial resistance

Surveillance systems overview for 2021

Increase of reported diphtheria cases among migrants in Europe due to Corynebacterium diphtheriae, 2022

Performance of lateral flow devices during the COVID-19 pandemic

Types of Influenza Viruses

WHO Global and Regional technical meeting on addressing NCDs in emergencies

Referral of influenza samples to RVU, UKHSA Colindale, 2022 to 2023

Climate and Health Strategic Framework | Climate and Health | CDC

Diphtheria treatment and vaccination simple text guide

World Health Organization WHO emergency preparedness mandate

Outbreak of Salmonella Mbandaka ST413 linked to chicken meat

Severe Acute Respiratory Infection (SARI) surveillance in secondary care - Respiratory surveillance - Respiratory infections - Conditions and diseases - Our areas of work - Public Health Scotland

Weekly influenza update, week 47, November 2022

Communicable disease threats report, 27 November – 3 December 2022, week 48

NHS facing "perfect storm" as flu admissions rise 40% in a week

Vaccine Glossary of Terms | CDC

Getting vaccines to those who need them most: Albania launches autumn influenza campaign and begins to roll out COVID-19 booster doses

COVID-19 disruptions in HIV testing and prevention highlight need for innovation and investment before the next public health emergency

Multi-country outbreak of mpox, External situation report #11 - 1 December 2022

Joint statement - Influenza season epidemic kicks off early in Europe as concerns over RSV rise and COVID-19 is still a threat

Technical report on the COVID-19 pandemic in the UK

CDC Changes Monkeypox Terminology to Mpox | 2022 | Dear Colleague Letters | NCHHSTP | CDC

WHO, WIPO, WTO to hold technical symposium on response, preparedness to future pandemics

Threats and outbreaks of salmonellosis

Weekly influenza update, week 46, November 2022

Third meeting of the Intergovernmental Negotiating Body (INB) for a WHO instrument on pandemic prevention, preparedness and response

Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 6 November 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland

Weekly national respiratory infection and COVID-19 statistical report 30 November 2022 - Weekly national respiratory infection and COVID-19 statistical report - Publications - Public Health Scotland

Joint report with the WHO Regional Office for Europe on HIV/AIDS surveillance – 2021 data

Concern over low rate of 2 to 3 year olds getting the flu vaccine

Investigating Salmonella and Wild Songbirds: A One Health Approach | One Health | CDC

Chemical and Biological Deliberate Events

WHO and U.S. Government donate mobile laboratory to Ukraine to strengthen infectious disease control

CBDE: Preparedness for Public Health Professionals

Report a COVID-19 rapid lateral flow test result

Diphtheria: Home Office ignored offer of help to manage migrant centre outbreak, say public health leaders

WHO supports Ukrainian health-care system as winter approaches

WHO recommends new name for monkeypox disease

One year of Omicron: the vital work of a WHO reference lab in the surveillance and diagnosis of viruses

Putting monkeypox front and centre: two journalists explain the importance of continuing to talk about the outbreak

Prevention, identification and management of infections in health workers in the context of COVID-19

10 ways you can fight air pollution

EMRG medium-term projections for COVID-19 hospitalisations and deaths: 9 November 2022

Women leaders in North Macedonia build trust in COVID-19 vaccination

One year since the emergence of COVID-19 virus variant Omicron

Communicable disease threats report, 20 - 26 November 2022, week 47

Quadripartite welcomes new political commitments in fight against antimicrobial resistance

COVID-19 statistical report - 23 November 2022 - COVID-19 statistical report - Publications - Public Health Scotland

Eligible people urged to get vaccinated as flu season officially under way

Episode #86 - Microbes are becoming resistant to antibiotics

KOICA & WHO highlight progress fighting antimicrobial resistance and future opportunities

International Lead Poisoning Prevention Week 2022 - campaign materials

‘Mass testing' linked to 25% cut in covid-19 related hospital admissions | BMJ

WHO Malaria Policy Advisory Group (MPAG) meeting (October 2022)

Measles is now "an imminent threat" globally, WHO and CDC warn

Children environmental health - Burden of diseases

Testing & Management Flu and SARS-COV-2 in Nursing Homes

Weekly national seasonal respiratory report - Week 46 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland

The first meeting of the multisectoral committee on  antimicrobial resistance is held

Monkeypox vaccines technical documents

RSV virus expected to add pressure on hospitals in many EU/EEA countries this season

COVID-19 statistical report - 23 November 2022 - COVID-19 statistical report - Publications - Public Health Scotland

COVID-19 NMA Summary Report

Monkeypox: Single dose of smallpox vaccine offers 78% protection, UKHSA reports

Together We Can Improve How We Use Antibiotics and Antifungals | TATFAR | Antibiotic/Antimicrobial Resistance | CDC

Consultation launched to protect patients from silent pandemic of antimicrobial resistance

Investigation of SARS-CoV-2 variants: technical briefings

Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022

Paxlovid Associated with Decreased COVID-19 Hospitalizations ..

Monkeypox response in Europe

European Antibiotic Awareness Day 2022 - launch event

WHO EPI-WIN webinar: Emerging biological threats: what are they and why are they a risk

Statement – Winter in Ukraine: people's health cannot be held hostage

COP27: Countries agree "loss and damage" fund to help poorer countries hit by climate disasters

ESPAUR report 2021 to 2022: infographics accessible text

WHO R&D Blueprint for Epidemics

NOIDs causative agents: week 46 (week ending 20 November 2022)

English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) report

Health in the green economy : health co-benefits of climate change mitigation - transport sector

WHO to identify pathogens that could cause future outbreaks and pandemics

New data shows 148 severe antibiotic-resistant infections a day in 2021

1 in 3 use antibiotics without prescription, WHO/Europe's study shows

Responding to malaria in urban areas: a new framework from WHO and UN-Habitat

Interim analysis of COVID-19 vaccine effectiveness in healthcare workers, an ECDC multi-country study, May 2021–July 2022

Generic protocol for ECDC studies of COVID-19 vaccine effectiveness against confirmed SARS-CoV-2 using healthcare worker cohorts, version 2.0

Covid-19: "Grotesque inequity" that only a quarter of paxlovid courses go to poorer countries

Fiji, the UN and partners deploy medical personnel and supplies in solidarity with Tuvalu's COVID-19 response effort

Ambient air pollution data

12th meeting of the European Environment and Health Task Force

ASPHER - ASPHER Climate Action through Public Health Education & Training

Communicable disease threats report, 13-19 November 2022, week 46

Covid-19: Is the UK still tracking the virus—and other questions answered

The flu jab in pregnancy

Quadripartite launches a new platform to tackle antimicrobial resistance threat to human and animal health and ecosystems

WHO/ECDC report: antimicrobial resistance a serious threat to patient safety in European Region

Tackling emerging antimalarial drug resistance in Africa

What's the big deal about antimicrobial resistance?

World Antimicrobial Awareness Week: Prevent antimicrobial resistance together

Differences in COVID-19 Hospitalizations by Self-Reported Race and Ethnicity in a Hospital in Honolulu, Hawaii

Background document for the SAGE October 2022 session on monkeypox vaccines

NHS COVID-19 app statistics

Fact Sheet: HIV Drug Resistance

35 000 annual deaths from antimicrobial resistance in the EU/EEA

Studies provide latest ‘real world' evidence on effectiveness of covid-19 treatments | BMJ

Antimicrobial consumption in the EU/EEA (ESAC-Net) - Annual Epidemiological Report for 2021

Antimicrobial resistance in the EU/EEA (EARS-Net) - Annual epidemiological report for 2021

Assessing the health burden of infections with antibiotic-resistant bacteria in the EU/EEA, 2016-2020

Monkeypox: a detailed profile of the disease

Vaccines and immunization for monkeypox: Interim guidance, 16 November 2022

What You Should Know about Flu Antiviral Drugs

COVID-19 statistical report - 16 November 2022 - COVID-19 statistical report - Publications - Public Health Scotland

Middle East respiratory syndrome: global summary and assessment of risk - 16 November 2022

Influenza virus characterization - Summary Europe, September 2022

Weekly national seasonal respiratory report - Week 45 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland

WHO Director-General's opening remarks at the COVID-19 and other diseases media briefing – 16 November 2022

WHO Vaccine Prioritization Working Group.  Summary of the evaluations and recommendations on the three Sudan ebolavirus vaccines that are candidates for inclusion in the planned ring vaccination trial in Uganda ("Tokomeza Ebola)

Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 23 October 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland

European Region's 20th year of polio-free status confirmed – but there is no room for complacency

COVID-19 Vaccine Delivery Partnership - October 2022

WHO's Infection prevention & control department

Antibiotic Resistance, Food, and Food Animals

Covid-19: NICE rejects five treatments over uncertain evidence and price in draft guidance

Regional meeting on the implementation of the Tuberculosis Action Plan for the WHO European Region 2023–2030 for high-priority countries

Phylogenetic Analysis of SARS-CoV-2 in Ontario | Public Health Ontario

Vaccination after SARS-CoV-2 infection linked to a decrease in long covid symptoms | BMJ

Covid-19: Funding for pandemic preparedness being "sucked away" by war in Ukraine

EMRG medium-term projections for COVID-19 hospitalisations and deaths: 26 October 2022

Weekly influenza update, week 44, October-November 2022

Diphtheria warn and inform letter

Communicable disease threats report, 6-12 November 2022, week 45

Diphtheria: public health control and management in England

Health Studies Program - Chemical Exposures - Poison Center and Public Health Collaborations Community of Practice Newsletters | CDC

COVID-19 Clinical Care Pathway

Priorities for Hospital Core Element Implementation | Antibiotic Use | CDC

COVID-19–Associated Hospitalizations Among U.S. Infants Aged <6 Months — COVID-NET, 13 States, June 2021–August 2022

New Study Shows Benefits of Flu Vaccination During Pregnancy

Notes from the Field: Outbreak of Ebola Virus Disease Caused by Sudan ebolavirus — Uganda, August–October 2022

COP27 Joint Quadripartite Side event - Integrating the environment into One Health

Vaccine access: World's poorest people suffer at the hands of free market dynamics, says WHO

USAAW 2022: Focusing on Prevention

WHO, WIPO, WTO to hold technical symposium on response, preparedness to future pandemics

Investigation Details | Listeria Outbreak Linked to Deli Meat and Cheese | CDC

Donors making a difference: Climate change and its impact on health

COVID-19 statistical report - 9 November 2022 - COVID-19 statistical report - Publications - Public Health Scotland

WHO guiding principles for pathogen genome data sharing

WHO releases first data on global vaccine market since COVID-19

Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 9 November 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland

Weekly national seasonal respiratory report - Week 44 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland

CPR Strategy | CDC

WHO Emergency Appeal: Ebola Disease Outbreak in Uganda

Rapid Risk Assessment: Risk of Sudan virus to EU/EEA citizens considered very low

WHO Director-General's remarks at the Youth Day at High Level Speakers Session COP27 – 9 November 2022

Global Vaccine Market Report 2022

Covid-19: Evusheld protects the most vulnerable patients, analysis shows

National flu and COVID-19 surveillance reports: 2021 to 2022 season

Cleaning and Disinfecting Your Facility

Extended call for experts: Technical Advisory Group on Risk Communication and Community Engagement in the WHO European Region

World Leaders Launch Forests and Climate Leaders' Partnership to accelerate momentum to halt and reverse forest loss and land degradation by 2030

Statement – Climate change is already killing us, but strong action now can prevent more deaths

Emerging Fairer & Stronger from COVID-19: Health System Imperatives - National Academy of Medicine

Advancements in Influenza Vaccines

Preventing and managing outbreaks of acute respiratory illness (ARI) in the Children and Young People Secure Estate (CYPSE)

Flu and acute respiratory illness (ARI) in prisons and other prescribed places of detention (PPDs)

Influenza Update N° 431

Prevention and Antiviral Treatment of Bird Flu Viruses in People | Avian Influenza (Flu)

Bird Flu in Pets and Other Animals | Avian Influenza (Flu)

NIH's Climate and Health Initiative tackles global health effects associated with a changing climate

Bird flu: rules in disease control and prevention zones in England

Bird flu (avian influenza): latest situation in England

Bird flu: rules if you keep game birds

Communicable Disease Threats Report, 30 October-5 November 2022, week 44

Research at APHA

Guidance for Maritime Vessels on the Mitigation and Management of COVID-19 | Quarantine | CDC

Malta launches first-ever national health workforce strategy

CBDE: Preparedness for Health First Responders

Routine Vaccination Coverage — Worldwide, 2021

Epidemiologic and Clinical Features of Children and Adolescents Aged <18 Years with Monkeypox — United States, May 17–September 24, 2022

Pregnancy and coronavirus (COVID-19)

Evidence for "substantial" monkeypox transmission before symptoms | BMJ

COVID-19 outreach programmes to migrant workers: evaluating VCSOs role

Viral Haemorrhagic Fever including Ebola Virus Disease | Public Health Ontario

Posters and Factsheets | Communication Resources | Ebola (Ebola Virus Disease) | CDC

COVID-19 and TB

Monkeypox in the U.S.

Early Wave of Flu Brings Early Flu Hospitalizations

Severe Monkeypox in Hospitalized Patients — United ...

Weekly influenza update, week 42, October 2022

Be Antibiotics Aware Toolkit

WHO Director-General's opening remarks at 12th ACT Accelerator Facilitation Council Meeting – 28 October 2022

Ebola disease caused by Sudan Ebola virus – Uganda

Influenza Antiviral Drug Resistance | CDC

Communicable Disease Threats Report, 23-29 October 2022, week 43

Monkeypox can be fatal for people with weak immune systems, CDC warns

World Polio Day in Ukraine: focus on urgent need to vaccinate against polio to prevent further spread

WHO Director-General's opening remarks at Member State Information Session on COVID-19 and other issues – 27 October 2022

ACT-Accelerator launches six month plan as world transitions to long-term COVID-19 control

TAG-VE statement on Omicron sublineages BQ.1 and XBB

10 facts on tuberculosis

Monkeypox – Africa CDC

About SAGE and COVID-19 - GOV.UK

Tuberculosis deaths and disease increase during the COVID-19 pandemic

RKI - Unit 32: Surveillance - Systematic Surveillance for SARS-CoV-2 in wastewater

Influenza virus characterization - Summary Europe, June 2022

Global tuberculosis report 2022

Severe Monkeypox in Hospitalized Patients — United States, August 10–October 10, 2022 | MMWR

How It Spreads | Monkeypox | Poxvirus | CDC

Weekly epidemiological update on COVID-19 - 26 October 2022

Global Tuberculosis Report 2022 Factsheet

Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 2 October 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland

Weekly national seasonal respiratory report - Week 42 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland

COVID-19 statistical report - 26 October 2022 - COVID-19 statistical report - Publications - Public Health Scotland

Getting a Flu Vaccine and a COVID-19 Vaccine at the Same Time | CDC

WHO fungal priority pathogens list to guide research, development and public health action

Responding to dengue outbreak in Nepal

COVID-19

New WHO Global Air Quality Guidelines aim to save millions of lives from air pollution

Laboratory support for SARS-CoV-2 virus neutralisation in the EU/EEA - a pilot study

Standard operating procedures: responding to a poliovirus event or outbreak, version 4

Guidance for Screening and Caring for Pregnant Women with Ebola Virus Disease for Healthcare Providers in U.S. Hospitals | Ebola Hemorrhagic Fever | CDC

Guidance on Air Medical Transport (AMT) for Patients with Ebola Virus Disease (EVD) | Ebola Hemorrhagic Fever | CDC

Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing

World Polio Day 2022: Joint statement by Commissioners Stella Kyriakides, Jutta Urpilainen, and Director of ECDC Dr Andrea Ammon

High monkeypox vaccine acceptance among male users of smartphone-based online gay-dating apps in Europe

Spread of the SARS-CoV-2 Omicron variant sub-lineage BQ.1 in the EU/EEA

Interim Clinical Considerations for Use of JYNNEOS and ACAM2000 Vaccines during the 2022 U.S. Monkeypox Outbreak | Monkeypox | Poxvirus | CDC

Examining Animals With Suspected Monkeypox | Monkeypox | Poxvirus | CDC

A Health Equity Approach for Implementation of JYNNEOS Vaccination at Large, Community-Based LGBTQIA+ Events — Georgia, August 27–September 5, 2022 | MMWR

Receipt of First and Second Doses of JYNNEOS Vaccine for Prevention of Monkeypox — United States, May 22–October 10, 2022 | MMWR

WHO Director-General's remarks at the World Polio Day 2022 and Beyond event  - 21 October 2022

World Health Organization (WHO) response to the External Evaluation of the Access to COVID-19 Tools Accelerator (ACT-A)

Characteristics of JYNNEOS Vaccine Recipients Before and During a Large Multiday LGBTQIA+ Festival — Louisiana, August 9–September 5, 2022 | MMWR

Communicable disease threats report, 16-22 October 2022, week 42

New Omicron sub-lineage likely to cause further increase in covid-19 cases

Cholera: WHO rations vaccines to preserve stocks amid rising outbreaks | The BMJ

Introduction to Nipah virus disease | OpenWHO

IANPHI and WHO Partner to Strengthen Public Health Functions and Health Emergency Preparedness | IANPHI

Effectiveness of Monovalent mRNA Vaccines Against COVID-19–Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States — IVY Network, 18 States, December 26, 2021–August 31, 2022 | MMWR

Progress Toward Poliomyelitis Eradication — Pakistan, January 2021–July 2022 | MMWR

WHO announces the update of the Consolidated Guidelines on HIV Testing Services (update 2022–23)

Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance — VISION Network, 10 States, December 2021—August 2022 | MMWR

Schools & Child Care | Monkeypox | Poxvirus | CDC

Intervention Services for People with or Exposed to Monkeypox | Monkeypox | Poxvirus | CDC

WHO Director-General's opening remarks at 3rd meeting of the IHR Emergency Committee: multi-country outbreak of monkeypox - 20 October 2022

Building next generation sequencing capacity for SARS-CoV-2 through workforce strengthening in Kyrgyzstan

Influenza Update N° 430

Science Brief: Detection and Transmission of Monkeypox Virus | Monkeypox | Poxvirus | CDC

Ebola PPE Frequently Asked Questions | Personal Protective Equipment (PPE) | Public Health Planners | Ebola (Ebola Virus Disease) | CDC

Strategic & Technical Advisory Group on Infectious Hazards with Pandemic and Epidemic Potential (STAG-IH)

Gonococcal antimicrobial susceptibility surveillance in the European Union/European Economic Area - Summary of results for 2020

Management and safe disposal of COVID-19 vaccination waste at health facility level

Statement on the thirteenth meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic

Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 25 September 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland

Shortage of cholera vaccines leads to temporary suspension of two-dose strategy, as cases rise worldwide

COVID-19 statistical report - 19 October 2022 - COVID-19 statistical report - Publications - Public Health Scotland

COVID-19 vaccination: a guide on pregnancy and breastfeeding - GOV.UK

Weekly national seasonal respiratory report - Week 41 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland

Guidelines & Publications | West Nile Virus | CDC

4 things to know about COVID-19 treatment in the Pacific

WHO Director-General's speech at "Investing in a Polio-free Future for More Resilient Health Systems", World Health Summit - 18 October 2022

Action plan: National workforce capacity to implement the essential public health functions including a focus on emergency preparedness and response

Monkeypox multi-country outbreak - second update

One health joint plan of action (‎2022‒2026)‎: working together for the health of humans, animals, plants and the environment

Q&A: Influenza in the context of COVID-19

Ocular Monkeypox — United States, July–September 2022 | MMWR

Call for consultant: Alliance for Transformative Action on Climate and Health (ATACH)

Avian influenza: Prevention Zone declared across Great Britain - GOV.UK

One Health Joint Plan of Action launched to address health threats to humans, animals, plants and environment

WHO Director-General's speech on Ports to Arms Approach to Access: Supercharging ACT-A for Future Pandemics, World Health Summit - 16 October 2022

Estimating seasonal influenza burden across the disease severity pyramid

Influenza pandemic preparedness planning in the Islamic Republic of Iran

COVID-19 statistical report - 12 October 2022 - COVID-19 statistical report - Publications - Public Health Scotland

Influenza in the northern hemisphere is back

WHO's Infodemic Management live! Online storytelling event

Covid-19: Booster vaccines rolled out as hospital admissions rise | The BMJ

Global antimicrobial resistance (AMR) research agenda in human health: a call for expert contributions

Weekly national seasonal respiratory report - Week 40 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland

WHO-WIPO-WTO Workshop : Innovation and Access to diagnostics for COVID-19 and beyond

Communicable disease threats report, 9-15 October 2022, week 41

USAID Provides $1.5 Million for COVID-19 Vaccine Rollout Support in Lao PDR

Viral Haemorrhagic Fever including Ebola Virus Disease | Public Health Ontario

External Evaluation of the Access To COVID-19 Tools Accelerator (ACT-A)

Fourth informal, focused consultation in relation to a new international instrument on pandemic prevention, preparedness and response: One Health and antimicrobial resistance, climate change and zoonoses

Updated e-course on Climate Change Negotiations and Health

WHO Emergency Appeal: Monkeypox - July 2022 – June 2023

WHO Director-General's opening remarks at the Member State Information Session on COVID-19 and other issues – 13 October 2022

WHO Director-General's opening remarks at the 13th meeting of the IHR Emergency Committee on COVID-19 pandemic – 13 October 2022

WHO Faith Network Webinar - The Importance of Language: Faith partner resources for health emergencies

Guidance for School Administrators to Help Reduce the Spread of Seasonal Influenza in K-12 Schools | CDC

Time to act to curb antimicrobial resistance now

Interim Guidance on Risk Assessment and Management of Persons with Potential Ebola Virus Exposure | Quarantine | CDC

Cholera - Haiti

Donors making a difference in Pakistan's flood crisis

Monkeypox Considerations for Sexual Health Services | 2022 | Dear Colleague Letters | NCHHSTP | CDC

Solidarity clinical trial for COVID-19 treatments

Donors making a difference: The European Union teams up with WHO to boost COVID-19 vaccination coverage in Africa

Ebola outbreak in Uganda under ECDC monitoring

Monkeypox: Virus DNA is widespread in treatment rooms, study finds | The BMJ

Pandemic influenza preparedness framework: progress report, 1 January - 30 June 2022

WHO Director-General's opening remarks at media briefing – 12 October 2022

Webinars on Climate Change Negotiations and Health

Framework for collaborative action on tuberculosis and comorbidities

Joint statement: Working together towards COVID-19 and seasonal influenza vaccinations for this winter

Community leaders in Georgia called upon to promote COVID-19 vaccination

Weekly national seasonal respiratory report - Week 39 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland

WHO Director-General's opening remarks at high-level emergency ministerial meeting on cross-border collaboration for preparedness and response to ebola virus disease - 12 October 2022

Guidance on Air Medical Transport (AMT) for Patients with Ebola Virus Disease (EVD) | Emergency Services | Clinicians | Ebola (Ebola Virus Disease) | CDC

Tenth meeting of the Working Group on Health in Climate Change

COVID-19 PPE guide for adult social care services and settings - GOV.UK

Vaccine-preventable disease update: reported diphtheria cases in the WHO European Region, 2022: 10 October 2022

Covid-19: Antiviral purchased by UK government does not lower risk of hospital admission, trial shows | The BMJ

National flu immunisation programme 2022 to 2023 letter - GOV.UK

External quality assessment (EQA) of the performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net), 2021

Covid-19: Hospital admissions rise in England as some trusts reinstate mask requirements | The BMJ

Evusheld: Government is urged to expedite covid antibody treatment for vulnerable patients | The BMJ

Hopeful not helpless: How doctors are combating climate change | The BMJ

Navigating the Tripartite Zoonoses Guide (TZG): A training for

Exploring the Role of Health Professional Students and Trainees as Members of the Health Workforce During Crises: Proceedings of a Workshop |The National Academies Press

Decision on Evusheld as a COVID-19 treatment - GOV.UK

Safety Information for Monkeypox Vaccine | Vaccine Safety | CDC

Drug-resistant tuberculosis treatment | OpenWHO

Communicable disease threats report, 2-8 October 2022, week 40

Episode #81 - Public Health Emergency of International Concern

Interim Clinical Considerations for Management of Ocular Monkeypox Virus Infection | Monkeypox | Poxvirus | CDC

Update on monkeypox in Scotland - News - Public Health Scotland

WHO EPI-WIN Webinar: What we know about influenza and COVID-19

Weekly national seasonal respiratory report - Week 39 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland

Increased diphtheria cases in migrant reception centres in Europe

COVID-19 statistical report - 5 October 2022 - COVID-19 statistical report - Publications - Public Health Scotland

Increase of reported diphtheria cases among migrants in Europe due to Corynebacterium diphtheriae, 2022

Multi-country outbreak of monkeypox, External situation report #7 - 5 October 2022

Pakistan: UN renews appeal to avert public health disaster in wake of climate induced floods | The BMJ

Global technical meeting on MERS-CoV and other emerging zoonotic coronaviruses - meeting summary

WHO Emergency Appeal: Health Crisis in Flood-Affected Pakistan

Learning lessons from the pilots: overcoming knowledge gaps around the malaria vaccine schedule in support of vaccine uptake

WHO Director-General's opening remarks at the media briefing – 5 October 2022

Delivering quality health services to refugees and migrants from Ukraine

Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 11 September 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland

Influenza virus characterization - Summary Europe, May 2022

European Region-wide case studies show how communicating risks and engaging communities are key to saving lives in health emergencies

Clinical Signs and Symptoms of Influenza | CDC

Supporting Individual Risk Assessment during COVID-19 |The National Academies Press

Artificial Intelligence Tools and Open Data Practices for EPA Chemical Hazard Assessments: Proceedings of a Workshop - in Brief | Artificial Intelligence Tools and Open Data Practices for EPA Chemical Hazard Assessments: Proceedings of a Workshopâ€"in Brief |The National Academies Press

Influenza Update N° 429

CDC - Malaria - Diagnosis & Treatment (United States) - Treatment (U.S.) - Guidelines for Clinicians

ASPHER - ASPHER Programme for Public Health Competencies

Evolving Crisis Standards of Care and Ongoing Lessons from COVID-19: Proceedings of a Workshop Series |The National Academies Press

Developing and implementing a national genomic surveillance strategy – Türkiye's experience

Managing outbreaks and incidents - GOV.UK

Avian influenza overview June – September 2022

Testing and detection of zoonotic influenza virus infections in humans in the EU/EEA, and occupational safety and health measures for those exposed at work

Flu vaccination guidance for Personal Assistants (PAs) - GOV.UK

COVID-19 Strategic Preparedness and Response Plan 2022: Global Monitoring and Evaluation Framework

Therapeutics and COVID-19: Living guideline, 16 September 2022

WHO announces updates to its guidelines on tests for the diagnosis of TB infection

WHO consolidated guidelines on tuberculosis: module 3: diagnosis: tests for TB infection

Communicable disease threats report, 25 September - 1 October 2022, week 39

WHO operational handbook on tuberculosis: module 3: diagnosis: tests for tuberculosis infection

Working hand in hand to manage COVID‑19 laboratory quality

The TAP manual: an in-depth guide for planning and implementing tailoring antimicrobial resistance programmes

COVID-19 - information and guidance for social, community and residential care settings - version 2.4 - COVID-19 - information and guidance for social, community and residential care settings (including care homes for older people registered with the Care Inspectorate) - Publications - Public Health Scotland

Similarities and Differences between Flu and COVID-19​ | CDC

Effectiveness of a Second COVID-19 Vaccine Booster Dose Against Infection, Hospitalization, or Death Among Nursing Home Residents — 19 States, March 29–July 25, 2022 | MMWR

UK childhood vaccination rates fell last year in almost all programmes, figures show | The BMJ

COVID-19 Vaccine Delivery Partnership - August 2022

WHO costing and budgeting tool for national action plans on

6 steps for sustainable implementation of national action plans on antimicrobial resistance

Spread of hepatitis A virus strains of genotype IB in several EU countries and the United Kingdom

Monthly operational update on COVID-19 - September 2022

War in Ukraine: situation report from WHO Ukraine country office: Issue No. 25, 28 September 2022

Weekly national seasonal respiratory report - Week 38 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland

Parents are urged to vaccinate 2-3 year olds against flu as NHS warns of "twindemic" | The BMJ

COVID-19 statistical report - 28 September 2022 - COVID-19 statistical report - Publications - Public Health Scotland

New dashboard presents integrated data on winter flu and COVID-19 vaccine programme - News - Public Health Scotland

Reducing Stigma in Monkeypox Communication and Community Engagement | Monkeypox | Poxvirus | CDC

Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 4 September 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland

Annexes to the interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19

Health and safety during COVID-19: training for health workers in south-eastern Europe

Achieving Zero Rabies deaths through One Health Approach

Ebola: After You Travel | Quarantine | CDC

WHO's response to COVID-19 - 2022 Mid-Year Report

Monkeypox - Conditions and diseases - Our areas of work - Public Health Scotland

Statement: The European Region is in a "permacrisis" that stretches well beyond the pandemic, climate change and war

Avian influenza prevention zone declared in Norfolk, Suffolk and parts of Essex - GOV.UK

‘Foreign disinformation' social media campaigns linked to falling vaccination rates | BMJ

2021-2022 data show largest avian flu epidemic in Europe ever

Climate and Health Evaluation Framework | CDC

The EU experience in the first phase of COVID-19: implications for measuring preparedness

WHO releases a public health taxonomy for social listening on monkeypox conversations

The WHO global infodemic manager community of practice is growing and tackling COVID-19, monkeypox and other outbreaks

WHO Director-General's opening remarks at the COVID-19 Global Action Plan Ministerial Meeting, New York, USA - 23 September 2022

WHO Director-General's opening remarks at the UNGA UNSG-hosted event: "Ending the pandemic through equitable access to COVID-19 vaccines, tests and treatments" – 23 September 2022

JCVI statement on vaccine dose prioritisation in response to the monkeypox outbreak - GOV.UK

Why we are changing our COVID-19 reporting - Our blog - Public Health Scotland

Investigation into monkeypox outbreak in England: technical briefing 8 - GOV.UK

Safety and side effects - COVID-19 vaccine information and resources - COVID-19 vaccinations - COVID-19 - Conditions and diseases - Our areas of work - Public Health Scotland

Guidance for General Population Disaster Shelters During the COVID-19 Pandemic | CDC

Second vaccine doses to be offered to those at highest risk from monkeypox - GOV.UK

Monkeypox - Conditions and diseases - Our areas of work - Public Health Scotland

Monkeypox Vaccine Equity Toolkit | Monkeypox | Poxvirus | CDC

Maintaining a safe and adequate blood supply and collecting convalescent plasma in the context of the COVID-19 pandemic

Congregate Living Settings | Monkeypox | Poxvirus | CDC

Pandemic influenza risk management: a WHO guide to inform and harmonize national and international pandemic preparedness and response

4. A(H3N2) - Cell culture-derived - Southern Hemisphere 2023

Covid-19: Cases rise in England and Wales as hospital admissions remain steady | The BMJ

EPI-WIN webinar: WHO monkeypox technical briefing for the transport and tourism sector

Episode 79 Is poliovirus making a comeback

Communicable disease threats report, 18-24 September 2022, week 38

New recommendations for the composition of influenza vaccines in 2023 for the southern hemisphere

WHO South-East Asia Region polio-free, accelerated efforts needed in view of increased risks: experts

COVID-19 health protection guidance - COVID-19 - Conditions and diseases - Our areas of work - Public Health Scotland

Monkeypox in a Young Infant — Florida, 2022 | MMWR

The Global Leaders Group host side event at UN General Assembly on Antimicrobial Resistance (AMR)

Seventy years of GISRS – the Global Influenza Surveillance & Response System

ACT-Accelerator Facilitation Council Working Group Report on Diagnostics and Therapeutics

No time for COVID-19 complacency, say key countries responsible for tracking global rollout of COVID-19 vaccines, tests and treatments

Surveillance and information sharing operational tool: an operational tool of the tripartite zoonoses guide

Multi-country outbreak of monkeypox, External situation report #6 - 21 September 2022

National protocol for Comirnaty® Original/Omicron BA.1 (15/15 micrograms)/dose COVID-19 mRNA vaccine - GOV.UK

Key highlights from the UN General Assembly side event: Progress and multisectoral action towards achieving global targets to end TB

Influenza Update N° 428

EVD-LabNet Webinar on tick-borne encephalitis in Europe

Autopsy and Handling of Human Remains of Patients with Monkeypox | Monkeypox | Poxvirus | CDC

Monkeypox: NHS offers tecovirimat for severe or complicated cases | The BMJ

Global vaccine safety blueprint 2.0 (‎GVSB2.0)‎ 2021-2023

Therapeutics and COVID-19: Living guideline, 16 September 2022

Triangulation in Environmental Epidemiology for EPA Human Health Assessments: Proceedings of a Workshop |The National Academies Press

Monkeypox in a Young Infant — Florida, 2022 | MMWR

The Influenza Imperative: An Urgent Need to Leverage Lessons from COVID-19 to Prepare for a Global Response to Seasonal and Pandemic Influenza - National Academy of Medicine

400 000 doses of Comirnaty vaccine delivered to Ukraine under COVAX

Pilot protocol for a COVID-19 vaccine effectiveness study using health data registries

Fourth WHO Global Evidence Review on Health and Migration stresses that equitable access to and appropriate use of antibiotics for refugees and migrants is essential to tackling Antimicrobial Resistance

Capturing the evidence on access to essential antibiotics in refugee and migrant populations

Appendix C - Incident Command System Incident Action Plan | A Pandemic Playbook for Transportation Agencies |The National Academies Press

Health Care Personnel Exposures to Subsequently Laboratory-Confirmed Monkeypox Patients — Colorado, 2022 | MMWR

Seasonal Influenza Vaccine Safety: A Summary for Clinicians | CDC

Children and Flu Antiviral Drugs | CDC

WHO strongly advises against antibody treatments for covid-19 patients | BMJ

Communicable disease threats report, 11-17 September 2022, week 37

Call for Expression of Interest: Rapid (Scoping) Review of Trust in Science in Public Health Emergencies

Training Workshop in Risk Communication

Forum on Medical and Public Health Preparedness for Disasters and Emergencies: 2020 Annual Report |The National Academies Press

EPI-WIN webinar: Managing stigma and discrimination in health care settings in public health emergencies such as monkeypox

Monkeypox Collection

Donors making a difference in the fight against polio

Weekly national seasonal respiratory report - Week 36 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland

COVID-19 - information and guidance for social, community and residential care settings - version 2.3 - COVID-19 - information and guidance for social, community and residential care settings - Publications - Public Health Scotland

WHO Director-General's opening remarks at the launch of The Lancet COVID-19 Commission Final Report – 15 September 2022

Clinical Considerations for Pain Management of Monkeypox | Monkeypox | Poxvirus | CDC

Mortality Risk Among Patients Hospitalized Primarily for COVID-19 During the Omicron and Delta Variant Pandemic Periods — United States, April 2020–June 2022 | MMWR

Flu Vaccine Safety and Pregnancy | CDC

Clinical management of COVID-19: Living guideline, 15 September 2022

Syndromic surveillance summary: 15 September 2022 week 36 - GOV.UK

NIH-funded team develops method to identify future SARS-CoV-2 mutations that could affect rapid antigen test performance | National Institutes of Health (NIH)

Malaria vaccines: preferred product characteristics and clinical development considerations

Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 21 August 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland

A guide to the COVID-19 autumn booster - GOV.UK

Covid-19: Commission describes "massive global failures" of pandemic response | The BMJ

WHO policy brief: Reaching COVID-19 vaccination targets, 14 September 2022

WHO policy brief: Maintaining infection prevention and control measures for COVID-19 in health care facilities, 14 September 2022

WHO policy brief: Building trust through risk communication and community engagement, 14 September 2022

Workplaces and Businesses | Monkeypox | Poxvirus | CDC

WHO policy brief: COVID-19 infodemic management, 14 September 2022

WHO policy brief: COVID-19 testing, 14 September 2022

WHO policy brief: Clinical management of COVID-19, 14 September 2022

Detection of circulating vaccine derived polio virus 2 (cVDPV2) in environmental samples– the United Kingdom of Great Britain and Northern Ireland and the United States of America

Call for Expression of Interest: Science Translation manual for public health emergencies: Section for media/communication professionals

COVID-19 policy briefs

Health and care workforce in Europe: time to act

Ticking timebomb: Without immediate action, health and care workforce gaps in the European Region could spell disaster

Frequently Asked Questions | Monkeypox | Poxvirus | CDC

Monkeypox Toolkit for Institutions of Higher Education | Monkeypox | Poxvirus | CDC

Two Cases of Monkeypox-Associated Encephalomyelitis — Colorado and the District of Columbia, July–August 2022 | MMWR

Improving risk communication in public health crises: Interview with Dr Savoia, speaker at ECDC's risk communication workshop

Six emergency management courses recognized for high-quality learning

Monkeypox outbreak: epidemiological overview, 13 September 2022 - GOV.UK

Statement by European Commissioner for Health and Food Safety Stella Kyriakides and WHO Regional Director for Europe Dr Hans Henri P. Kluge on preventing monkeypox from becoming endemic in Europe

Weekly national seasonal respiratory report - Week 35 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland

WHO Director-General's opening remarks at the 72nd Session of the WHO Regional Committee for Europe – 12 September 2022

Call for Experts – Quadripartite Technical Group on the Economics of AMR (QTG-EA)

HM Prison and Probation Service COVID-19 Statistics, August 2022 - GOV.UK

Resilience of age-friendly environments during the COVID-19 pandemic: lessons learnt from 12 European cities

Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol — United States, May–August 2022 | MMWR

New fund for pandemic prevention, preparedness and response formally established

Toolkits for Community, Work, and School | Monkeypox | Poxvirus | CDC

U.S. clinical trial evaluating antiviral for monkeypox begins | National Institutes of Health (NIH)

Ireland tracks its way to COVID-19 vaccine delivery success

Novavax COVID-19 vaccine Nuvaxovid approved by MHRA - GOV.UK

Eligible groups - COVID-19 vaccine information and resources - COVID-19 vaccinations - COVID-19 - Our areas of work - Public Health Scotland

Communicable disease threats report, 4-10 September 2022, week 36

WHO South-East Asia Region roadmap to strengthen emergency preparedness and response

Clinical Trial Evaluating Monkeypox Vaccine Begins | National Institutes of Health (NIH)

WHO Director-General's opening remarks at the Inaugural meeting of the Governing Board of the Financial Intermediary Fund for Pandemic Prevention, Preparedness and Response – 8 September 2022

Second round of public hearings in relation to a new international instrument on pandemic prevention, preparedness and response

Infection prevention and antimicrobial stewardship - the role of nurses in preventing AMR

War in Ukraine: situation report from WHO Ukraine country office. Issue No.22, 7 September 2022

Multi-country outbreak of monkeypox, External situation report #5 - 7 September 2022

One Health in action against Neglected Tropical Diseases | OpenWHO

WHO releases new repository of resources for air quality management

International Day of Clean Air for blue skies: joint efforts needed to tackle air pollution driving climate change and affecting health

Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 14 August 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland

Empowering Field Epidemiologists for Stronger Health Systems: World Field Epidemiology Day 2022

Framework and toolkit for infection prevention and control in outbreak preparedness, readiness and response at the health care facility level

MR Lab Network

Actions to strengthen resilience of health workers in south-eastern Europe in response to COVID-19 and beyond: implementation of WHO/ILO guidance and mapping of priority needs for occupational health and safety programmes for health workers

CDC Monkeypox Response Leadership Update | 2022 | Dear Colleague Letters | NCHHSTP | CDC

Monkeypox outbreak: epidemiological overview, 6 September 2022 - GOV.UK

Access community-based treatments for coronavirus (COVID-19) - GOV.UK

COVID-19: recommendations on use of adapted vaccines

Agenda for the Ministerial Lunch on Resetting the course towards ending tuberculosis and AIDS, and eliminating the epidemics of viral hepatitis and sexually transmitted infections in the WHO European Region

Investing in the COVID-19 Response through the ACT-Accelerator: Long-Term Benefits

WHO releases new module of the PrEP implementation tool on integration of STI services

Imagining the future of pandemics and epidemics: a 2022 perspective

Human resources for medical devices, the role of biomedical engineers

Monkeypox: The State of the Science

STIs in 2022: emerging and re-emerging outbreaks

New strategies to tackle and end STIs epidemics

Antiviral Drugs for Seasonal Influenza: Additional Links and Resources | CDC

Regulatory approval of Pfizer/BioNTech bivalent Original/Omicron booster vaccine - GOV.UK

4 Vaccine Distribution and Delivery | Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines |The National Academies Press

Cell-Based Flu Vaccines | CDC

Multidrug-Resistant Strain of Salmonella Newport | Salmonella | CDC

Lab Alert: MPXV TNF Receptor Gene Deletion May Lead to False Negative Results with Some MPXV Specific LDTs

Investigation into monkeypox outbreak in England: technical briefing 7 - GOV.UK

Expansion of polio sewage surveillance to areas outside London - GOV.UK

Priorities, actions and technical support of the IPC pillar of the regional COVID-19 Incident Management Support Team

US and Canada to roll out the first omicron specific boosters within days | The BMJ

UK monkeypox case numbers continue to decline - GOV.UK

Latest update on monkeypox in Scotland - News - Public Health Scotland

WHO Director-General's remarks at the Monkeypox Outbreak: virtual dialogue between affected communities and WHO leadership Geneva, Switzerland – 2 September 2022

COVID-19 Vaccine Delivery Partnership - July 2022

Communicable disease threats report, 28 August-3 September 2022, week 35

Tuberculosis - Annual Epidemiological Report for 2020

Pakistan floods pose serious health challenges | The BMJ

Recommendations from the WHO Technical Advisory Group on Safe Schooling During the COVID-19 Pandemic: revised version following the eighth TAG meeting, 20 January 2022

CDC Recommends the First Updated COVID-19 Booster | CDC Online Newsroom | CDC

WHO delivers ambulances to Ukraine amid ongoing attacks against health care

World Antimicrobial Awareness Week 2022

Parental Intentions and Perceptions Toward COVID-19 Vaccination Among Children Aged 4 Months to 4 Years — PROTECT Cohort, Four States, July 2021–May 2022 | MMWR

COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months–5 Years — United States, June 18, 2022–August 21, 2022 | MMWR

Flu Vaccination by Jet Injector | CDC

Strategies Adopted by Gay, Bisexual, and Other Men Who Have Sex with Men to Prevent Monkeypox virus Transmission — United States, August 2022 | MMWR

Travel ban implemented to protect public health following Denmark COVID-19 mink outbreak - GOV.UK

Weekly national seasonal respiratory report - Week 34 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland

Support Program to combat current and Future Public Health Threats (Labour Management Procedures Report) – Africa CDC

Training and tools

War in Ukraine: situation report from WHO Ukraine country office. Issue No.21, 31 August 2022

Monkeypox Vaccination Basics | Monkeypox | Poxvirus | CDC

WHO Director-General's opening remarks at media briefing – 31 August 2022

Covid alert level reduced to two - GOV.UK

Avian influenza prevention zone declared in south-west England - GOV.UK

Italy and Mexico turn to Cuban doctors to fill gaps in underserved regions | The BMJ

COVID-19 vaccination programme - GOV.UK

Statement: Control, elimination, eradication: three actions we need to take on three different public health emergencies in the European Region in the coming months

Monthly operational update on COVID-19 - August 2022

Monkeypox outbreak: epidemiological overview, 30 August 2022 - GOV.UK

Health authorities working with community stakeholders to control Monkeypox in Portugal

WHO Director-General's opening remarks at 12th meeting of the Technical Advisory Group on Behavioural Insights and Sciences for Health– 30 August 2022

Half of health care facilities globally lack basic hygiene services – WHO, UNICEF

5000 micro-influencers in Portugal build confidence in COVID-19 vaccination

Sex-on-premises venues playing their part to end the monkeypox outbreak

Weekly epidemiological record, 2022, vol. 97, 34 (full issue)

EPI-WIN webinar: Omicron BA.5: What do we know about new COVID variants of concern?

New policy briefs support country strategies to control and eliminate monkeypox in the WHO European Region

SARS-CoV-2 antigen levels linked to patient outcomes | National Institutes of Health (NIH)

Sex-on-premises venues playing their part to end the monkeypox outbreak

A TB laboratory on wheels in Timor-Leste

Long-term qualitative scenarios and considerations of their implications for preparedness and response to the COVID-19 pandemic in the EU/EEA

The COVID-19 Risk Communication Package For Healthcare Facilities

WHO EpiBrief, No. 1/2022

COVID-19: epidemiological update. Weekly report. Week 33. 25 August 2022.

NHS Workforce Statistics, May 2022 - GOV.UK

Latest update on monkeypox - Scotland - News - Public Health Scotland

Strategies Adopted by Gay, Bisexual, and Other Men Who Have Sex with Men to Prevent Monkeypox virus Transmission — United States, August 2022 | MMWR

Summary: ‘Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2022-23’

Communicable disease threats report, 21-27 August, week 34

Cholera kits 2020

Catalyzing action in states to combat antimicrobial resistance

Episode #77 - Hepatitis outbreak in children 76 Monkeypox Who is at risk

Parliamentarians: Resilient health systems and preparedness for future emergencies critical to health security in Asia and the Pacific

Adjuvanted Flu Vaccine | CDC

Building Trust in Public Health Emergency Preparedness and Response (PHEPR) Science: Proceedings of a Workshop - in Brief | Building Trust in Public Health Emergency Preparedness and Response (PHEPR) Science: Proceedings of a Workshop–in Brief |The National Academies Press

Influenza (Flu) Vaccine Safety | CDC

Notes From the Field: Coccidioidomycosis Outbreak Among Wildland Firefighters — California, 2021 | MMWR

WHO Target Product Profiles for Monkeypox Therapeutics

High-Contact Object and Surface Contamination in a Household of Persons with Monkeypox Virus Infection — Utah, June 2022 | MMWR

NIH experts review monkeypox challenges | National Institutes of Health (NIH)

Surveillance, case investigation and contact tracing for Monkeypox: Interim guidance

Covid-19: Asymptomatic testing is "paused" in England's hospitals and care homes | The BMJ

WHO Director-General's opening remarks at the COVID-19 media briefing– 25 August 2022

WHO Academy offers virtual course on acute respiratory infection

Kick-off meeting held to plan the new biennium's pandemic influenza preparedness partnership contribution funds supported activity work plan

Inadvertent vaccination in pregnancy (VIP) - GOV.UK

COVID-19 and other respiratory viruses: mitigating their spread as children return to school across Europe

Toughest targets ever introduced will crack down on sewage spills - GOV.UK

Multi-country outbreak of monkeypox, External situation report #4 - 24 August 2022

Annexes to the interim recommendations for use of the Valneva VLA2001 vaccine against COVID-19

At least 80 million children under one at risk of diseases such as diphtheria, measles and polio as COVID-19 disrupts routine vaccination efforts, warn Gavi, WHO and UNICEF

War in Ukraine: situation report from WHO Ukraine country office. Issue No.20, 24 August 2022

Multi-drug resistant gonorrhoea

EpiData, 2/2022

Eighth external quality assessment scheme for Listeria monocytogenes typing

COVID-19: testing during periods of low prevalence - GOV.UK

Regular asymptomatic testing paused in additional settings - GOV.UK

After six months of war, Ukraine's life-saving health system prepares for a challenging winter ahead

COVID Infection Survey - GOV.UK

Sexually transmitted infections: North East data - GOV.UK

Generic protocol for COVID-19 vaccine effectiveness studies at long-term care facilities in the EU/EEA

Strengthening Medical Oxygen Ecosystem Through Lessons Learnt During COVID-19 Pandemic

Monkeypox: Fractional vaccine doses will be piloted as new treatment trial launches | The BMJ

Antibody treatment protects adults against malaria | National Institutes of Health (NIH)

WHO, EU support the Philippines' vaccine information system

Frequently Asked Influenza (Flu) Questions: 2022-2023 Season | CDC

Interim recommendations for use of the Valneva VLA2001 vaccine against COVID-19

New mobile friendly web tool with interactive dashboard gives individuals the information they need on monkeypox in advance of attending gatherings

Summary of Possible Multistate Enteric (Intestinal) Disease Outbreaks | CDC

Awareness-raising on Antimicrobial Resistance: Report of global consultation meetings

100 000 doses of the Janssen vaccine delivered to Ukraine under COVAX

Monkeypox: what we know about the 2022 outbreak so far | The BMJ

Background document on the Valneva VLA2001 vaccine against COVID-19

Public call for data on targeted Next-Generation Sequencing solutions for detection of drug resistance among people diagnosed with tuberculosis

Call for applications to join the Alliance for Transformative Action on Climate and Health

Report of a WHO expert consultation on dosing to enable implementation of treatment recommendations in the WHO consolidated guidelines on the management of TB in children and adolescents

WHO Director-General's opening remarks at the 72nd session of the Regional Committee for Africa – 22 August 2022

Monkeypox vaccines to be piloted in smaller but equally effective doses - GOV.UK

Vaccines and immunization for monkeypox: Interim guidance, 24 August 2022

Monkeypox: UKHSA laboratory assessments of inactivation methods - GOV.UK

Risk communication and community engagement (RCCE) resources

Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 24 July 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland

Investigation and management of outbreaks of suspected acute viral respiratory infection in schools: guidance for health protection teams - GOV.UK

Weekly national seasonal respiratory report - Week 32 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland

Call for public consultation - Target Product Profile (TPP) for readers of rapid diagnostic tests (RDT readers)

COVID-19: epidemiological update. Weekly report. Week 32. 18 August 2022.

What People Who Raise Pigs Need To Know About Influenza (Flu) | CDC

High-Contact Object and Surface Contamination in a Household of Persons with Monkeypox Virus Infection — Utah, June 2022 | MMWR

UK monkeypox case numbers show overall decline - GOV.UK

Investigation into monkeypox outbreak in England: technical briefing 6 - GOV.UK

Monkeypox

Schools, Early Care and Education Programs, and Other Settings Serving Children or Adolescents | Monkeypox | Poxvirus | CDC

Polio Investigation Information for Clinicians | CDC

Polio Investigation Information for Health Departments  | CDC

Communicable disease threats report, 14-20 August 2022, week 33

Covid-19: Results from India's 12 molnupiravir clinical trials remain unpublished | The BMJ

Resources for health professionals on monkeypox

CDC - Malaria - Features - World Mosquito Day 2022

Monkeypox situation update, as of 18 August 2022

Latest update on monkeypox covering Scotland - News - Public Health Scotland

WHO makes new recommendations for Ebola treatments, calls for improved access

Therapeutics for Ebola virus disease

Progress Toward Measles Elimination — South-East Asia Region, 2003–2020 | MMWR

WHO Guidelines for malaria

Autochthonous transmission of dengue virus in mainland EU/EEA, 2010-present

Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5–11 Years — United States, May 17–July 31, 2022 | MMWR

Monkeypox: UK to run out of vaccine doses by next week | The BMJ

Interim recommendations for use of the Valneva VLA2001 vaccine against COVID-19

Technical consultation on the malaria rebound phenomenon

Annexes to the recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19

Annexes to the recommendations for use of the Pfizer–BioNTech vaccine BNT162b2 against COVID-19

Transition of COVID-19 Hospital Reporting | NHSN | CDC

Clinical characteristics of COVID-19

War in Ukraine: situation report from WHO Ukraine country office. Issue No.19, 17 August 2022

Sustainability framework for action against NTDs 2021–2030 | OpenWHO

Covid-19: What have been the direct and indirect health impacts in England? | The BMJ

Public health taxonomy for social listening on monkeypox conversations

Listeria: enhanced surveillance questionnaire - GOV.UK

Covid-19: UK will roll out Moderna's omicron BA.1 vaccine as part of autumn booster programme | The BMJ

Fighting current and future coronaviruses with a single vaccine | National Institutes of Health (NIH)

Monkeypox outbreak: epidemiological overview, 16 August 2022 - GOV.UK

Public Health Response to a Case of Paralytic Poliomyelitis in an Unvaccinated Person and Detection of Poliovirus in Wastewater — New York, June–August 2022 | MMWR

Winter vaccine resources for healthcare workers - Publications - Public Health Scotland

Update on the polio situation in the EU/EEA and the world

WHO releases updated guidance on national strategic planning for tuberculosis

Open call for experts to serve as members of the WHO/Europe One Health Advisory Group

Apply to be a member of the WHO Task Force of Antimicrobial Resistance (AMR) Survivors: Call for expressions of interest

EUR/RC71/BG/11 Results of the Member States' web-based consultation on the draft progress report on implementation of the Action Plan to improve public health preparedness and response in the WHO European Region 2018–2023

Covid-19: UK will not buy Evusheld owing to "insufficient data" on protection, government says | The BMJ

Guidance for national strategic planning for tuberculosis

Update on vaccination to protect against monkeypox in England - GOV.UK

JCVI publishes advice on COVID-19 vaccines for autumn booster programme - GOV.UK

Review of Fate, Exposure, and Effects of Sunscreens in Aquatic Environments and Implications for Sunscreen Usage and Human Health National Academies of Sciences, Engineering, and Medicine. 2022. Review of Fate, Exposure, and Effects of Sunscreens in Aquatic Environments and Implications for Sunscreen Usage and Human Health

COVID-19: the green book, chapter 14a - GOV.UK

Control of Neglected Tropical Diseases

WHO R&D Blueprint for Epidemics

Lab Advisory: FDA Advises Repeat Testing to Reduce False Negative Results with COVID-19 Antigen Tests

Monkeypox: experts give virus variants new names

Monkeypox (MPX) Overview for Disease Intervention Specialists (DIS) and Others Providing Intervention Services to People with or Exposed to MPX | Monkeypox | Poxvirus | CDC

MGN 652 (M+F) Amendment 1 infectious disease at sea - GOV.UK

2018–2019 Estimated Flu Illnesses, Medical Visits, Hospitalizations, and Deaths Prevented by Vaccination | CDC

Communicable disease threats report, 7-13 August 2022, week 32

Covid-19: Study provides further evidence that mRNA vaccines are safe in pregnancy | The BMJ

Latest monkeypox update - Scotland - News - Public Health Scotland

Call for appointment to the WHO panel of experts for FAO/WHO Joint Meeting on Pesticide Management (JMPM)

Benefits of Getting A COVID-19 Vaccine | CDC

Summary of Guidance for Minimizing the Impact of COVID-19 on Individual Persons, Communities, and Health Care Systems — United States, August 2022 | MMWR

CDC streamlines COVID-19 guidance to help the public better protect themselves and understand their risk | CDC Online Newsroom | CDC

Emergency in Ukraine: external situation report #19, published 11 August 2022: reporting period: 28 July–10 August 2022

COVID-19 Self-Test Data: Challenges and Opportunities — United States, October 31, 2021–June 11, 2022 | MMWR

Interim Guidance for Prevention and Treatment of Monkeypox in Persons with HIV Infection — United States, August 2022 | MMWR

Notes from the Field: School-Based and Laboratory-Based Reporting of Positive COVID-19 Test Results Among School-Aged Children — New York, September 11, 2021–April 29, 2022 | MMWR

Epidemiologic and Clinical Characteristics of Monkeypox Cases — United States, May 17–July 22, 2022 | MMWR

National norovirus and rotavirus surveillance reports: 2022 to 2023 season - GOV.UK

Polio vaccine is offered to all children in London aged 1 to 9 after virus detected in sewage | The BMJ

Weekly national seasonal respiratory report - Week 31 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland

Langya henipavirus under ECDC monitoring

Polio Vaccine Composition, Dosage, Administration, and Administration Errors | CDC

Polio booster campaign resources - GOV.UK

All children aged 1 to 9 in London to be offered a dose of polio vaccine - GOV.UK

Interim statement on COVID-19 vaccination for children

Clinical management of COVID-19

Inactivated polio vaccine (IPV) booster: information for healthcare practitioners - GOV.UK

Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 17 July 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland

Polio vaccination campaign letter - GOV.UK

War in Ukraine: situation report from WHO Ukraine country office. Issue No.18, 10 August 2022

Vaccination Administration Considerations for Specific Populations | Monkeypox | Poxvirus | CDC

Vaccination Strategies | Monkeypox | Poxvirus | CDC

JYNNEOS Vaccine | Monkeypox | Poxvirus | CDC

ACAM2000 Vaccine | Monkeypox | Poxvirus | CDC

Monkeypox outbreak: epidemiological overview, 9 August 2022 - GOV.UK

Influenza Update N° 425

Monkeypox outbreak: epidemiological overview - GOV.UK

EUR/RC71/BG/11 Results of the Member States' web-based consultation on the draft progress report on implementation of the Action Plan to improve public health preparedness and response in the WHO European Region 2018–2023

Advisory Committee on Immunization Practices (ACIP) Work Groups | CDC

Child Health in Complex Emergencies |The National Academies Press

R&D Blueprint and Monkeypox

Monkeypox: Concerns mount over vaccine inequity | The BMJ

Clinical Recognition | Monkeypox | Poxvirus | CDC

Investigation into monkeypox outbreak in England: technical briefing 5 - GOV.UK

Janssen Jcovden® (Johnson & Johnson) COVID-19 vaccine - Canada.ca

Take Action to Prevent the Spread of Flu Between Pigs and People | CDC

Pathogen Reduction & Decolonization | CDC

Polio Vaccine: Vaccine-Derived Poliovirus | CDC

Interim Guidance for Prevention and Treatment of Monkeypox in Persons with HIV Infection — United States, August 2022 | MMWR

Monkeypox outbreak: epidemiological overview, 5 August 2022 - GOV.UK

UK monkeypox case numbers begin to plateau - GOV.UK

Epidemiologic and Clinical Characteristics of Monkeypox Cases — United States, May 17–July 22, 2022 | MMWR

Latest update on monkeypox in Scotland - News - Public Health Scotland

EMRG medium-term projections for COVID-19 hospitalisations and deaths: 20 July 2022 - GOV.UK

About the outbreak toolkit project

Management of critical COVID-19 Advanced non-invasive respiratory support: high-flow nasal oxygen and non-invasive ventilation- Part 2

Management of critical COVID-19: Acute hypoxaemic respiratory failure and COVID-19

Communicable disease threats report, 31 July - 6 August, week 31

Climate crisis: Wellcome sells some fossil fuel investments as climate leaders call for full divestment | The BMJ

WHO Meeting of the Global Influenza Surveillance and Response System: From 70th Anniversary to 100 Years

Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years — United States, July 2022 | MMWR

Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Novavax COVID-19 Vaccine

Outbreaks of Acute Gastrointestinal Illness Associated with a Splash Pad in a Wildlife Park — Kansas, June 2021 | MMWR

Supporting the deployment of COVID-19 vaccines and routine vaccination systems in the Eastern Partnership: Armenia

Preparation and administration of mAb114 for Ebola virus disease (‎EVD)

Monoclonal antibody prevents malaria in U.S. adults, NIH trial shows | National Institutes of Health (NIH)

Weekly national seasonal respiratory report - Week 30 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland

WHO Methodology for Point Prevalence Survey on Antibiotic Use in Hospitals

ASPHER - Member's blog - Other

SAVE THE DATE - Scientific strategies from recent outbreaks to help us prepare for Pathogen X

War in Ukraine: situation report from WHO Ukraine country office: Issue No. 17, 3 August 2022

Assessment of workforce capacity and training needs for the prevention and control of communicable diseases in the EU/EEA - Report on 2021 survey

Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 10 July 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland

Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 3 August 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland

Unity Studies: Early Investigation Protocols

Data Dissemination Resources | Surveillance Overview | Statistics Center | HIV/AIDS | CDC

Monkeypox outbreak: epidemiological overview, 2 August 2022 - GOV.UK

Methods for the detection and characterisation of SARS-CoV-2 variants - second update

References | Toward a Post-Pandemic World: Lessons from COVID-19 for Now and the Future: Proceedings of a Workshop |The National Academies Press

Summary of Product Characteristics for Vaxzevria - GOV.UK

Monkeypox: diagnostic testing - GOV.UK

Vaccine Effectiveness: How Well Do Flu Vaccines Work? | CDC

Covid-19: Ontario hospitals close wards as nursing shortage bites | The BMJ

Hepatitis (liver inflammation) cases in children – latest updates - GOV.UK

Reporting form for AEFI

5 PFAS Testing and Concentrations to Inform Clinical Care of Exposed Patients | Guidance on PFAS Exposure, Testing, and Clinical Follow-Up |The National Academies Press

COVID-19: guidance for health professionals - GOV.UK

Who Should and Who Should NOT Get a Flu Vaccine | CDC

WHO Consultation on the Composition of Influenza Virus Vaccines for Use in the 2023 Southern Hemisphere Influenza Season

WHO publishes new guidelines on HIV, hepatitis and STIs for key populations

Communicable disease threats report, 24-30 July, week 30

Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations

Monitoring HIV pre-exposure prophylaxis programmes in the EU/EEA

ECDC expert consultation on knowledge and research gaps related to the COVID-19 public health response

Regional gatherings to strengthen pandemic influenza preparedness

Sustaining integrated surveillance in South-East Asia

WHO Monkeypox Research - What study designs can be used to address the remaining knowledge gaps for monkeypox vaccines?

Coronavirus disease (COVID-19) and people living with HIV

Isolation and Prevention Practices for People with Monkeypox | Monkeypox | Poxvirus | CDC

Clinical Considerations for Monkeypox in Children and Adolescents | Monkeypox | Poxvirus | CDC

WHO's Response to the Ukraine Crisis

Staying safe in the heat: health advice for times of extreme temperature and wildfires

WHO applauds agreement to scale-up generic manufacturing for access to long-acting injectable antiretrovirals

Patient information for Paxlovid - GOV.UK

Report of the Commission on Human Medicines Expert Working Group on COVID-19 vaccine safety surveillance - GOV.UK

Syndromic surveillance summary: 28 July 2022 week 29 - GOV.UK

Weekly national seasonal respiratory report - Week 29 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland

WHO recommends long-acting cabotegravir for HIV prevention

Guidelines on long-acting injectable cabotegravir for HIV prevention

WHO consultation on guidance development for conducting TB programme reviews

Public health impact of drought: advice for the public - GOV.UK

Malaria chemoprevention efficacy study protocol

SDG 11.6.2 Working Group: Final Meeting

Differentiated and simplified pre-exposure prophylaxis for HIV prevention: update to WHO implementation guidance

WHO launched new implementation guidance for simplified and differentiated service delivery of pre-exposure prophylaxis (PrEP)

WHO Director-General's opening remarks at the COVID-19 media briefing– 27 July 2022

Building a community of learning for women leaders in health emergencies

Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 27 July 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland

COMEAP advice note: Environment Act PM2.5 targets - GOV.UK

Monthly operational update on COVID-19 - July 2022

Good practices guidance handbook for national TB surveys: how to apply good clinical and good data management practices for national TB surveys

Monkeypox: WHO declares a public health emergency of international concern | The BMJ

Monkeypox: New clinical symptoms are identified in confirmed cases | The BMJ

Monkeypox: Symptoms seen in London sexual health clinics differ from previous outbreaks, study finds | The BMJ

Monkeypox: What's behind WHO's decision not to declare a public health emergency? | The BMJ

Monkeypox: Gay and bisexual men with high exposure risk will be offered vaccine in England | The BMJ

Monkeypox: Doctors in England will have to notify local agencies of all suspected cases | The BMJ

Monkeypox: What do we know about the outbreaks in Europe and North America? | The BMJ

Seven monkeypox cases are confirmed in England | The BMJ

Monkeypox outbreak: epidemiological overview, 26 July 2022 - GOV.UK

Statement: Vaccines alone won't end the monkeypox outbreak – at-risk individuals will have to take action too

Multi-country outbreak of monkeypox, External situation report #2 - 25 July 2022

Responding to the monkeypox outbreak: perspectives of clinicians treating patients with the disease

Enhance surveillance, public health measures for monkeypox: WHO

Second meeting of the International Health Regulations (2005) (IHR) Emergency Committee regarding the multi-country outbreak of monkeypox

WHO Director-General declares the ongoing monkeypox outbreak a Public Health Emergency of International Concern

Investigation into monkeypox outbreak in England: technical briefing 4 - GOV.UK

Monkeypox outbreak: epidemiological overview, 22 July 2022 - GOV.UK

Communicable disease threats report, 17 - 23 July, week 29

Latest monkeypox update - News - Public Health Scotland

Clinical Considerations for Treatment and Prophylaxis of Monkeypox Virus Infection in People with HIV | Monkeypox | Poxvirus | CDC

WHO Director-General's opening remarks at second meeting of the IHR Emergency Committee regarding the multi-country outbreak of monkeypox – 21 July 2022

2022 Monkeypox Outbreak Global Map | Monkeypox | Poxvirus | CDC

Monkeypox outbreak: epidemiological overview, 19 July 2022 - GOV.UK

Disinfecting Home and Other Non-Healthcare Settings | Monkeypox | Poxvirus | CDC

Clinical Considerations for Monkeypox in People Who are Pregnant or Breastfeeding | Monkeypox | Poxvirus | CDC

Latest update on monkeypox cases in Scotland - News - Public Health Scotland

Monkeypox: infected people who are isolating at home - GOV.UK

Global clinical data platform for monkeypox case report form (CRF)

Communicable disease threats report, 10 - 16 July, week 28

Monkeypox: semen testing for viral DNA - GOV.UK

Monkeypox outbreak: epidemiological overview, 15 July 2022 - GOV.UK

Frequently Asked Questions | Monkeypox | Poxvirus | CDC

Monkeypox outbreak: epidemiological overview, 12 July 2022 - GOV.UK

Investigation into monkeypox outbreak in England: technical briefing 3 - GOV.UK

Rapid Diagnostic Testing for Response to the Monkeypox Outbreak — Laboratory Response Network, United States, May 17–June 30, 2022 | MMWR

Monkeypox outbreak: epidemiological overview, 8 July 2022 - GOV.UK

Update on monkeypox in Scotland - News - Public Health Scotland

Monkeypox: continuing transmission in interconnected sexual networks - GOV.UK

Monkeypox situation update, as of 7 July 2022

ECDC releases first update to its Rapid Risk Assessment on the monkeypox outbreak

Multi-country outbreak of monkeypox, External situation report #1 - 6 July 2022

Joint WHO Regional Office for Europe/ECDC Monkeypox Resource toolkit to support national authorities and event organisers in their planning and coordination of mass and large gathering events

Monkeypox outbreak: epidemiological overview, 5 July 2022 - GOV.UK

HCID status of monkeypox - GOV.UK

What Healthcare Professionals Should Know | Monkeypox | Poxvirus | CDC

Monkeypox (MPX) Reporting Protocol 2022

Smallpox vaccination against monkeypox checklist - GOV.UK

Monkeypox: waiting for your vaccination - GOV.UK

Latest update on monkeypox in Scotland - News - Public Health Scotland

Monkeypox multi-country outbreak - first update

Communicable disease threats report, 3-9 July 2022, week 27

Monkeypox outbreak: Resource toolkit for event organisers

Communicable disease threats report, 26 June-2 July 2022, week 26

Monkeypox: planning events and mass gatherings - GOV.UK

Monkeypox outbreak: epidemiological overview, 1 July 2022 - GOV.UK

Considerations for Monkeypox Vaccination | Monkeypox | Poxvirus | CDC

WHO Director-General's opening remarks at the media briefing – 29 June 2022

ECDC publishes contact tracing guidance for the current monkeypox outbreak

Summary of the International Health Regulations (2005) Emergency Committee meeting regarding the multi-country monkeypox outbreak

Considerations for contact tracing during the monkeypox outbreak in Europe, 2022

Monkeypox outbreak: epidemiological overview, 28 June 2022 - GOV.UK

Multi-country monkeypox outbreak: situation update

Investigation into monkeypox outbreak in England: technical briefing 2 - GOV.UK

WHO Director-General's statement on the report of the Meeting of the International Health Regulations (2005) Emergency Committee regarding the multi-country monkeypox outbreak

Laboratory Procedures | Monkeypox | Poxvirus | CDC

For Public Health Veterinarians and Animal Health Officials | Monkeypox | Poxvirus | CDC

UKHSA urges those with new or multiple sexual partners to be vigilant as monkeypox outbreak grows - GOV.UK

Increase in monkeypox cases in Scotland as high-risk groups approved for vaccine - News - Public Health Scotland

Surveillance, case investigation and contact tracing for Monkeypox: Interim guidance

Risk communication and community engagement (RCCE) for monkeypox outbreaks: Interim guidance, 24 June 2022

Pets in the Home | Monkeypox | Poxvirus | CDC

Monkeypox

WHO Director-General's opening remarks at International Health Regulations (2005) Emergency Committee regarding the multi-country monkeypox outbreak – 23 June 2022

Monkeypox outbreak: epidemiological overview, 21 June 2022 - GOV.UK

Monkeypox outbreak: vaccination strategy - GOV.UK

Monkeypox vaccine to be offered more widely to help control outbreak - GOV.UK

Data on monkeypox cases in the EU/EEA

Treatment Information for Healthcare Professionals | Monkeypox | Poxvirus | CDC

Multi-country monkeypox outbreak: situation update

Monkeypox in Scotland - Update - News - Public Health Scotland

Communicable disease threats report, 12-18 June 2022, week 24

The WHO Global Clinical Platform for monkeypox

Navigating monkeypox: considerations for gay and bisexual men and other men who have sex with men

Monkeypox: urgently tackling a neglected disease, together

Epidemiological update: Monkeypox multi-country outbreak

ECDC and WHO publish joint technical report on navigating monkeypox during the summer season

Notifications of infectious diseases (NOIDs) - GOV.UK

Interim advice for public health authorities on summer events during the monkeypox outbreak in Europe, 2022

WHO Director-General's opening remarks at the COVID-19 media briefing– 14 June 2022

Vaccines and immunization for monkeypox: Interim guidance, 14 June 2022

Multi-country monkeypox outbreak: situation update

Update on Cases of Monkeypox in Scotland - News - Public Health Scotland

Investigation into monkeypox outbreak in England: technical briefing 1 - GOV.UK

Communicable disease threats report, 5-11 June 2022, week 23

Monkeypox outbreak 2022 - Global

Epidemiological update: Monkeypox multi-country outbreak

Monkeypox minimum dataset case reporting form (CRF)

Increasing preparedness and prevention measures for monkeypox

WHO consultations sets research priorities for monkeypox

Update on monkeypox in Scotland - News - Public Health Scotland

Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 | MMWR

Epidemiological update: Monkeypox multi-country outbreak

Monkeypox: secure and detained settings - GOV.UK

Principles for monkeypox control in the UK: 4 nations consensus statement - GOV.UK

WHO Director-General's opening remarks at the COVID-19 media briefing – 8 June 2022

Communicable disease threats report, 29 May -4 June 2022, week 22

Public health agencies issue monkeypox guidance to control transmission - GOV.UK

Additional case of monkeypox confirmed in Scotland - News - Public Health Scotland

Multi-country monkeypox outbreak in non-endemic countries: Update

Monkeypox EURO

De-isolation and discharge of monkeypox-infected patients: interim guidance - GOV.UK

Factsheet for health professionals on monkeypox

EPI-WIN webinar: Science Communication, Chatbots, COVID-19 and clarity: How tech enabled access to trusted information in local languages

Additional cases of monkeypox confirmed in Scotland - News - Public Health Scotland

Video: ECDC message on the monkeypox outbreak in the EU/EEA

Multi-country monkeypox outbreak in non-endemic countries

Monkeypox: case definitions - GOV.UK

ECDC presents monkeypox response options, as nine EU/EEA countries report cases

WHO working closely with countries responding to monkeypox

Laboratory testing for the monkeypox virus: Interim guidance

Risk assessment: Monkeypox multi-country outbreak

Monkeypox

WHO Monkeypox Research: What are the knowledge gaps and priority research questions?

First case of monkeypox confirmed in Scotland - News - Public Health Scotland

Multi-country monkeypox outbreak in non-endemic countries

Surveillance, case investigation and contact tracing for Monkeypox: Interim guidance

Monkeypox: Introductory course for African outbreak contexts | OpenWHO

Monkeypox multi-country outbreak

Epidemiological update: Monkeypox multi-country outbreak

Monkeypox

Monkeypox cases reported in UK and Portugal

Communicable disease threats report, 8-14 May 2022, week 19

Monkeypox outbreak: epidemiological update - GOV.UK

Management of suspected monkeypox in primary and community care - version 1 - Management of suspected monkeypox in primary and community care - Publications - Public Health Scotland

Questions and answers on monkeypox

Monkeypox vaccination - GOV.UK

1997 - Monkeypox

Monkeypox - GOV.UK

Monkeypox

Monkeypox - United Kingdom of Great Britain and Northern Ireland

First polio case in decades reported in the Americas | The BMJ

Ghana declares its first outbreak of Marburg virus disease after two deaths | The BMJ

New study updates evidence on rare heart condition after covid vaccination | BMJ

Covid-19: High prevalence and lack of hospital beds putting "intense pressure" on ambulances | The BMJ

WHO advises against use of two drugs for non-severe covid-19 | BMJ

Covid-19: Researchers face wait for patient level data from Pfizer and Moderna vaccine trials | The BMJ

Covid-19: Parts of England see hospital admissions more than double in two weeks | The BMJ

Covid-19: Hospitals and GP clinics return to universal mask wearing as rates rise | The BMJ

Covid-19: WHO urges countries to plug immunity gaps as global infections rise | The BMJ

New legislation places duty on NHS to tackle climate change | The BMJ

Emergency care plan is "inadequate" on every level, say doctors | The BMJ

Covid-19: GPs are asked to opt into next vaccination phase this autumn | The BMJ

WHO online consultation meeting to discuss global principles for identifying credible sources of health information on social media

New review of evidence highlights importance of ventilation to prevent spread of covid-19 | BMJ

Polio: What do we know about the polioviruses detected in the UK? | The BMJ

UK must focus on diagnostics needed to cut antimicrobial resistance, says review chair | The BMJ

Poliovirus is detected in sewage from north and east London | The BMJ

Wearable activity trackers + AI can pick up presymptomatic COVID-19 | BMJ

Covid-19: CDC and FDA approve Pfizer and Moderna vaccines for under 5s | The BMJ

Covid-19: Omicron sub variants driving new wave of infections in UK | The BMJ

Covid-19: Long covid risk is lower with omicron than delta, researchers find | The BMJ

NHS to rollout two new drugs to tackle superbugs | The BMJ

Covid-19: Second boosters may benefit at-risk groups but have "minimal" impact for others, says WHO | The BMJ

Covid-19: Two million people in the UK are estimated to be experiencing long covid, says ONS | The BMJ

Covid-19: True global death toll from pandemic is almost 15 million, says WHO | The BMJ

Hepatitis in children: What's behind the outbreaks? | The BMJ

Covid-19: JCVI advises further booster for vulnerable adults and health and care workers | The BMJ

NHS staff survey underlines need for national workforce strategy | The BMJ

Acute hepatitis is identified in more children, but cause remains elusive | The BMJ

Hepatitis: Ukrainian refugees should be offered vaccines and free treatment, says WHO | The BMJ

Scientists search for cause of hepatitis cases in children | The BMJ

We need to increase MMR uptake urgently | BMJ

Covid-19: Fourth dose of mRNA vaccines is safe and boosts immunity, study finds | The BMJ

Covid-19: Symptomatic infection with omicron variant is milder and shorter than with delta, study reports | The BMJ

Russian forces are increasingly targeting Ukrainian healthcare facilities, says WHO | The BMJ

Covid-19: UK adds sore throat, headache, fatigue, and six other symptoms to official list | The BMJ

Medical schools should include climate change in their curriculum, says report | The BMJ

Lasting cough could be TB, warns UK agency as cases rise | The BMJ

Quadrivalent Influenza Vaccine | CDC

Joint mission to western Ukraine assesses critical polio outbreak response

Guidance, tools and support for countries transitioning to digital, case-based surveillance for TB

One Health Initiative

Non-clinical evaluation of vaccines

Vaccine resources in other languages and alternative formats - COVID-19 vaccine information and resources - COVID-19 vaccinations - COVID-19 - Our areas of work - Public Health Scotland

Data at WHO

Personal Protective Equipment (PPE) portal - GOV.UK

Using the WHO online COVID-19 public health and social measures calibration tool: a step-by-step guide

RKI - COVID-19 - Interrupt chains of infection digitally with the Corona-Warn-App

Antimicrobial resistance in the EU/EEA (EARS-Net) - Annual Epidemiological Report for 2020

Update on Non A-E Hepatitis investigation in Scotland - News - Public Health Scotland

President's message for July 2022 - Groundhog Day: Climate emergency is with us again

WHO Drug Information - Volume 36, No. 2

WHO Strategic and Technical Advisory Group for Antimicrobial Resistance (STAG-AMR)

Identifying and responding to serious adverse events following immunization, following use of smallpox vaccine during a public health emergency: a guidance document for smallpox vaccine safety surveillance

Tools and strategies for successful scale-up of TB preventive treatment

Appendix A: groups included in the national influenza immunisation programme - GOV.UK

WHO Global Consultative Meeting on the Safe Shipment of Infectious Substances

Number of COVID-19 tests in defence and positive cases in the UK Armed Forces 2022 - GOV.UK

Guiding the evaluation of COVID-19 vaccine effectiveness

WHO preferred product characteristics for monoclonal antibodies for HIV prevention

Public health surveillance for COVID-19: interim guidance

Global surveillance of COVID-19: WHO process for weekly reporting aggregated data

COVID-19 guidance for prison settings - version 2.1 - COVID-19 guidance for prison settings - Publications - Public Health Scotland

Schistosoma – Serology | Public Health Ontario

Revised case report form for confirmed Novel Coronavirus COVID-19 (‎‎‎report to WHO within 48 hours of case identification)‎‎‎

COVID-19 testing in homelessness, domestic abuse refuge and respite room settings - GOV.UK

Global COVID-19 Vaccination Strategy in a Changing World: July 2022 update

WHO releases global COVID-19 vaccination strategy update to reach unprotected

Heatwave in Europe: local resilience saves lives – global collaboration will save humanity

EU/EEA routine surveillance open data policy

Final WHO SARS-CoV-2 serology test kit evaluation results

Tracking SARS-CoV-2 variants in wastewater | National Institutes of Health (NIH)

Influenza Activity and Composition of the 2022–23 Influenza Vaccine — United States, 2021–22 Season | MMWR

WHO Director-General's opening remarks at the Member State Information Session on COVID-19 and other issues - 21 July 2022

Weekly national seasonal respiratory report - Week 28 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland

Guidance for Cruise Ships on the Mitigation and Management of COVID-19 | Quarantine | CDC

Statement from NIH and BARDA on the Novavax COVID-19 Vaccine | National Institutes of Health (NIH)

War in Ukraine: situation report from WHO Ukraine country office. Issue No.15, 20 July 2022

WHO/BS/2022.2432: Report on the WHO collaborative study to establish Universal Reagents for the D-Antigen potency testing of Inactivated Polio Vaccines

Government sets out plan to reduce water pollution - GOV.UK

WHO Director-General's opening remarks at the COVID-19 media briefing– 20 July 2022

MI4A 2022 Public Database

Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 20 July 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland

MI4A 2022 Vaccine Product List

CDC Recommends Novavax's COVID-19 Vaccine for Adults | CDC Online Newsroom | CDC

Vaccine-Induced Immune Response to Omicron Wanes Substantially Over Time | National Institutes of Health (NIH)

Influenza of avian origin in UK seal populations: qualitative assessment of the risk to the UK human population - GOV.UK

WHO/BS/2022.2438: Report on the WHO collaborative study to investigate the utility of next generation sequencing (NGS) as a molecular test of virus stocks used in the manufacture of Type 1 and 2 Poliovirus vaccine (Oral)

Control of Neglected Tropical Diseases

Genomic sequencing used to investigate university halls outbreak in new study - News - Public Health Scotland

Rapidly escalating COVID-19 cases amid reduced virus surveillance forecasts a challenging autumn and winter in the WHO European Region

Reporting Death or Illness on Ships | Quarantine | CDC

WHO Director-General's remarks at COVID-19 Global Action Plan Foreign Ministerial Meeting – 19 July 2022

Free vaccinations for Ukrainian refugees in the Republic of Moldova

Call for expressions of interest: Expert(s) to conduct systematic reviews of the evidence on tuberculosis health-related risk factors

ECDC releases publications on COVID-19 vaccination strategies and joint ECDC-WHO report on considerations for respiratory diseases as guidance for the second half of the year

Preliminary public health considerations for COVID-19 vaccination strategies in the second half of 2022

Operational considerations for respiratory virus surveillance in Europe

Key Facts About Seasonal Flu Vaccine | CDC

Weekly epidemiological update on COVID-19 - 15 June 2022

Greater efforts needed to get routine immunization back to pre-COVID-19 times: WHO

Joint Committee on Vaccination and Immunisation (JCVI) updated statement on the COVID-19 vaccination programme for autumn 2022 - GOV.UK

2022 IANPHI Europe Meeting - Preparing for and Responding to Crises: What Role for National Public Health Institutes? | IANPHI

New COVID-19 Vaccine Effectiveness Data Showcase Protection Gained by 3rd and 4th Doses | CDC Online Newsroom | CDC

European Region averts further backsliding in routine immunization but falls short of full recovery

Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022 | MMWR

Heat-health advice issued for all regions of England - GOV.UK

Over 50s to be offered COVID-19 booster and flu jab this autumn - GOV.UK

Engaging multisectoral stakeholders to strengthen One Health

COVID-19 pandemic fuels largest continued backslide in vaccinations in three decades

WHO/UNICEF Immunization Coverage Estimates - 2021 revision

Moderna Spikevax COVID-19 vaccine - Canada.ca

Weekly all-cause mortality surveillance: 2022 to 2023 - GOV.UK

The WHO Global Clinical Platform for COVID-19

Interferon treatment may reduce severity of COVID-19 in people with certain genetic factors | National Institutes of Health (NIH)

Input to the WHO/UNICEF Estimates of National Immunization Coverage (WUENIC)

Antimicrobial Resistance in the EU/EEA - A One Health response

Therapeutics and COVID-19: living guideline

FAQ: COVID-19 Vaccine - Canada.ca

Interim recommendations on COVID-19 vaccination in autumn 2022 for the WHO European Region: conclusions and recommendations of the European Technical Advisory Group of Experts on Immunization

Call for submissions: Best practices on the engagement of affected communities and civil society in ending TB

Weekly Epidemiological Update on COVID-19 - 13 July 2022

Influenza Update N° 423

Patient Information Leaflet for COVID-19 Vaccine Valneva - GOV.UK

Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 13 July 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland

Expert advisory group recommends COVID-19 vaccination strategy for the autumn season

Bacterial vaccines in clinical and preclinical development 2021

Protect your child against flu – information for parents and carers - GOV.UK

WHO Director-General's opening remarks at the COVID-19 media briefing– 12 July 2022

Severe acute hepatitis of unknown aetiology in children - Multi-country

COVID-19 - guidance for health protection teams (HPTs) - version 2.4 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland

Statement on the twelfth meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic

Urgent call for better use of existing vaccines and development of new vaccines to tackle AMR

COVID-19 Contact tracing: country experiences and way forward

NIH launches clinical trial of mRNA Nipah virus vaccine | National Institutes of Health (NIH)

WHO announces updates on its guidance on tuberculosis care and support

WHO consolidated guidelines on tuberculosis: module 4: treatment: tuberculosis care and support

WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support

Updated joint statement from ECDC and EMA on additional booster doses of COVID-19 vaccines

ECDC and EMA update recommendations on additional booster doses of COVID-19 vaccines

Foresight approaches in global public health: a practical guide for WHO staff

Polio interactive map

EMRG medium-term projections for COVID-19 hospitalisations and deaths: 22 June 2022 - GOV.UK

Call for experts on risk assessment of microbiological hazards related to food safety

ECDC and WHO produce risk communication and community engagement advice, toolkit for public health authorities and event organisers

Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5–11 years in Italy - ISS

HIV Diagnoses | HIV and Gay and Bisexual Men | HIV by Group | HIV/AIDS | CDC

First WHO–UNCCT joint training on radiological and nuclear safety

WHO Director-General's opening remarks at the Member State Information Session on COVID-19 and other issues

Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 6 July 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland

WHO Director-General's opening remarks at 11th ACT-A Facilitation Council - 6 July 2022

WHO Director-General's opening remarks at the COVID-19 media briefing – 6 July2022

Contact tracing and quarantine in the context of COVID-19: interim guidance, 6 July 2022

Operational considerations for the provision of the HIV continuum of care for refugees from Ukraine in the EU/EEA

Climate Leader Video Campaign - National Academy of Medicine

Changes to the severity of COVID-19 and impact on hospitals in Scotland, January-April 2022 - Changes to the severity of COVID-19 and impact on hospitals in Scotland - Publications - Public Health Scotland

Poliomyelitis

A systematic approach to monitoring and analysing public health and social measures in the context of the COVID-19 pandemic: underlying methodology and application of the PHSM database and PHSM Severity Index: updated July 2022

Catalonia ensures COVID-19 vaccine interventions leave no community behind

Coronavirus disease (COVID-19): Home care for families and caregivers

ECDC launches e-learning course on how to address online vaccination misinformation

Influenza Update N° 422

UK Statement to the Seventh Review Meeting of the Joint Convention on the Safety of Spent Fuel Management and on the Safety of Radioactive Waste Management - GOV.UK

Understanding and using WHO guidelines on tuberculosis | OpenWHO

Vaccine hesitancy

ECDC-WHO/Europe COVID-19 Surveillance Explorer

Vaccine update: issue 330, June 2022, COVID-19 spring special edition - GOV.UK

Surveillance of influenza and other seasonal respiratory viruses in winter 2021 to 2022 - GOV.UK

Invasive meningococcal disease - Annual Epidemiological Report for 2018

Join the WHO/Europe #DoItAll campaign

Ebola virus disease

Call for experts: Quadripartite Technical Group on Antimicrobial Resistance and Use Integrated Surveillance (QTG-AIS)

Strengthening the health system response to COVID-19

Emergency in Ukraine: external situation report #15, published 16 June 2022: reporting period: 2–15 June 2022

Factsheet about Ebola virus disease

Reaching the unreached with COVID-19 vaccination across the Western Pacific Region

Evaluation of the flu and COVID-19 vaccination programmes in Scotland - interim report (November 2021) - Evaluation of the flu and COVID-19 vaccination programmes in Scotland - interim report (November 2021) - Publications - Public Health Scotland

Trial of potential universal flu vaccine opens at NIH Clinical Center | National Institutes of Health (NIH)

11th ACT-Accelerator Facilitation Council meeting

Q&A: How to combat the infodemic with digital solutions to reduce health risks during the COVID-19 pandemic and beyond

#EndTB Webinar: Supporting countries to transition to case-based, digital TB surveillance

Severe acute hepatitis of unknown aetiology in children - Multi-country

Statement of the Thirty-second Polio IHR Emergency Committee

COVID-19 variants identified in the UK – latest updates - GOV.UK

Joint external evaluation tool: International Health Regulations (‎2005)‎ - third edition

ACIP Flu Meeting Update: Flu Vaccines Worked Better than Reported & ACIP Recommends Specific Vaccines For Seniors

WHO Public Health Laboratories knowledge sharing webinars -  Scientific Writing Communication

Wild poliovirus type 1 (WPV1) – Mozambique

Clinical management of COVID-19: Living guideline, 23 June 2022

Commonwealth leaders recommit to ending malaria and neglected tropical diseases

Webinar: Individual Monitoring, Triage and Decontamination in Radiation Emergencies

Weekly national seasonal respiratory report - Week 24 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland

Download historical data (to 20 June 2022) on the weekly number of new reported COVID-19 cases and deaths worldwide

Infant and Young Child Feeding in Emergencies (IYCF-E) Toolkit

Health emergency preparedness for imported cases of high-consequence infectious diseases

COVID-19 information and guidance for workplaces and community settings- version 1.2 - COVID-19 information and guidance for workplaces and community settings - Publications - Public Health Scotland

Manual for monitoring insecticide resistance in mosquito vectors and selecting appropriate interventions

Vaccine-derived poliovirus type 2 (VDPV2) detected in environmental samples in London, UK

Immediate actions in response to detection of vaccine derived polio virus type 2 (VDPV2) in London sewage samples - GOV.UK

Poliovirus detected in sewage from North and East London - GOV.UK

Lack of innovation set to undermine antibiotic performance and health gains

ACT-Accelerator: Quarterly Update Q1: 1 January – 31 March 2022

Report from the scoping consultation on severe bacterial infections among people with advanced HIV disease

Hospitalization and Emergency Department Encounters for COVID-19 After Paxlovid Treatment — California, December 2021–May 2022 | MMWR

Indoor residual surface treatments for malaria transmission control in areas with insecticide-resistant mosquito populations

Monthly operational update on COVID-19 - June 2022

COVID-19 - guidance for health protection teams (HPTs) - version 2.3 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland

US NIH licenses to C-TAP

Understanding Viral Vector COVID-19 Vaccines | CDC

#PrepYourHealth: MyEvacuation Plan

WHO Public Health Laboratories knowledge sharing webinars -  Acute hepatitis of unknown aetiology in children: laboratory testing strategy guidance and epidemiological updates

Sixteenth meeting of the WHO Vector Control Advisory Group

COVID-19 vaccines and medicines: updates for June 2022 - GOV.UK

SIREN study - GOV.UK

Uptake of spring booster encouraged as COVID-19 cases rise across Scotland - News - Public Health Scotland

UK's top scientists join forces to battle bird flu outbreaks - GOV.UK

WHO Director-General's remarks at press conference following G20 Health Ministers Meeting – 20 June 2022

Surveillance, prevention and control of leishmaniases in the European Union and its neighbouring countries

COVID-19 Vaccination Interim Clinical Considerations FAQs | CDC

Quick Conversation Guide on COVID-19 Vaccines for Children | CDC

Investigation into acute hepatitis of unknown aetiology in children in England: case update - GOV.UK

CDC Experts and Global Partners Unite to Support Humanitarian Efforts in Ukraine  | Division of Global Health Protection | Global Health | CDC

Infection prevention and control (IPC) educational resources - COVID-19 health protection guidance - COVID-19 - Our areas of work - Public Health Scotland

A New Drug Target against Malaria | Institut Pasteur

Interim statement on decision-making considerations for the use of variant updated COVID-19 vaccines

Interim statement on the composition of current COVID-19 vaccines

WHO Director-General's remarks at the IX Baku Forum – 17 June 2022

Tonnes of COVID-19 health care waste expose urgent need to improve waste management systems

Chemical hazards and poisons report: issue 28 - GOV.UK

WHO mass gathering COVID-19 risk assessment tool: generic events, version 3

Global Clinical Platform

Call for Experts − WHO Strategic and Technical Advisory Group for Neglected Tropical Diseases

WHO consultation to adapt influenza sentinel surveillance systems to include COVID-19 virological surveillance: virtual meeting, 6 – 8 October 2020

Coronavirus disease (COVID-19) pandemic

Outbreaks and emergencies

Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 15 June 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland

Influenza Update N° 421

Guiding the evaluation of COVID-19 vaccine effectiveness

Digital solutions to health risks raised by the COVID-19 infodemic. Synthesis Report

Vaccine Taskforce to merge with UKHSA and OLS - GOV.UK

Connections (May-June 2022)

European Environment and Health Process (EHP)

WHO/Europe reports on the contribution of urban planning and management to resilience and health protection

COVID-19 guidance for prison settings - version 2 - COVID-19 guidance for prison settings - Publications - Public Health Scotland

SARS-CoV-2 in children

Implications of the emergence and spread of the SARS-CoV-2 variants of concern BA.4 and BA.5 for the EU/EEA

Highest-risk patients eligible for COVID-19 treatments: guide for patients - GOV.UK

EMRG medium-term projections for COVID-19 hospitalisations and deaths: 25 May 2022 - GOV.UK

Manual for investigating suspected outbreaks of illnesses of possible chemical etiology: guidance for investigation and control

COVID-19 and HIV | HIV Basics | HIV/AIDS | CDC

CDC Rescinds Order Requiring Negative Pre-Departure COVID-19 Test Prior to Flight to the US | CDC Online Newsroom | CDC

IANPHI COVID-19 Webinar Series | IANPHI

Cholera: Introduction | OpenWHO

Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 8 June 2022 - Repository - Public Health Scotland

WHO Director-General's keynote address at the WHO Global Tuberculosis Programme – 9 June 2022

COVID-19 Case Management Webinar Series: Care of the critical patient

£7 billion for NHS and social care for COVID-19 response and recovery - GOV.UK

Preliminary Report for the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO)

WHO Director-General's opening remarks at the  Member State Information Session on COVID-19 and other issues

COVID-19 vaccination efforts prove value of polio network for resilient health systems

Disease surveillance reports

COVID-19 surveillance and immunity studies up to March 2022 - GOV.UK

World Health Organization WHO emergency preparedness

Malaria Elimination | OpenWHO

Hospital onset COVID-19 mortality in Scotland - 7 March 2020 to 31 March 2022 - Hospital onset COVID-19 mortality in Scotland - Publications - Public Health Scotland

WHO Civil Society Task Force on TB: engagement with civil society as a driver for change: progress report, March 2020 - June 2021

Questions and answers on COVID-19: Current situation in the EU

Updated WHO recommendations for malaria chemoprevention among children and pregnant women

Updated WHO recommendations for malaria chemoprevention and elimination

One hundred days of war has put Ukraine's health system under severe pressure

Interim statement on hybrid immunity and increasing population seroprevalence rates

WHO Director-General's opening remarks at Scientific Advisory Group for the Origins of Novel Pathogens (SAGO), first in-person meeting – 1 June 2022

EMRG medium-term projections for COVID-19 hospitalisations and deaths: 11 May 2022 - GOV.UK

HelicsWin.Net (HWN)

MediPIET

Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 15 May 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland

How has the COVID-19 pandemic affected children and young people in Scotland? - News - Public Health Scotland

ECDC issues guidance on scaling up capability and capacity to characterise SARS-CoV-2 variants

World Hepatitis Summit 2022 urges action to eliminate viral hepatitis as unexplained hepatitis cases in children rise globally

WHO guideline for the treatment of visceral leishmaniasis in HIV co-infected patients in East Africa and South-East Asia 

Maintaining infection prevention and control measures for COVID-19 in health care facilities: Policy brief, 7 June 2022

Defining the highest-risk clinical subgroups upon community infection with SARS-CoV-2 when considering the use of neutralising monoclonal antibodies (nMABs) and antiviral drugs: independent advisory group report

Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 25 May 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland

Launch of Scenario Hub projecting future COVID-19 health impact

World Health Assembly approves recommendations to support people living with NCDs in humanitarian emergencies

Mobilizing young people to promote vaccination against COVID-19 in the Republic of Moldova

Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine

Technical guidance for antigenic SARS-CoV-2 monitoring

Severity of disease associated with Omicron variant as compared with Delta variant in hospitalized patients with suspected or confirmed SARS-CoV-2 infection

NERVTAG and EMG: Role of aerosol transmission in COVID-19 - 22 July 2020 - GOV.UK

Human resources for health in small countries: developing and sustaining postgraduate training: policy brief

Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 1 June 2022 - Repository - Public Health Scotland

Update on the investigation into higher than usual rates of hepatitis in children - News - Public Health Scotland

Acute hepatitis of unknown aetiology in children - Multi-country

An integrated approach to building health systems resilience | OpenWHO

COVID-19 vaccine tracker and landscape

Sinopharm [Vero Cell]- Inactivated, COVID-19 vaccine

Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 25 May 2022 - Repository - Public Health Scotland

Weekly national seasonal respiratory report - Week 20 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland

Director-General's opening remarks at the Strategic Roundtable on Health Emergency Preparedness and Response – 26 May 2022

Guidance for diagnostic testing of cases with severe acute hepatitis of unknown aetiology in children

Major improvements in quality of life for people with drug-susceptible TB expected following updates in TB treatment regimens

Global report on infection prevention and control

Understanding the behavioural and social drivers of vaccine uptake WHO position paper – May 2022

UKHSA expands support to help countries identify emerging variants - GOV.UK

Pandemic prevention, preparedness and response accord

Joint Committee on Vaccination and Immunisation (JCVI) interim statement on the COVID-19 vaccination programme for autumn 2022 - GOV.UK

Understanding the transmission of antibiotic resistance in Staphylococcus aureus | Institut Pasteur

COVAX calls for urgent action to close vaccine equity gap

Epidemiological update issued 19 May 2022: hepatitis of unknown aetiology in children

Influenza A(H1N1) - Germany

Interim recommendations for use of the Cansino Ad5-nCoV-S vaccine (Convidecia ®) against COVID-19

Weekly national seasonal respiratory report - Week 19 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland

JCVI provides interim advice on an autumn COVID-19 booster programme - GOV.UK

WHO guidelines on tuberculosis infection prevention and control: 2019 update

Global Influenza Programme

WHO validates 11th vaccine for COVID-19

WHO information note on ensuring continuity of essential tuberculosis services for people with or at risk of the disease within Ukraine and in refugee-hosting countries

WHO issues Information Note on ensuring continuity of essential TB services for people with or at risk of the disease in Ukraine and refugee-hosting countries

Immunization, Vaccines and Biologicals

Joint FAO/OIE/WHO Preliminary Risk Assessment Associated with Avian Influenza A(H3N8) Virus

Table 3: WHO recommendations for routine immunization

COVID-19 Aviation Health Safety Protocol: Operational guidelines for the management of air passengers and aviation personnel in relation to the COVID-19 pandemic

Indicator Metadata Registry List

COVID-19: epidemiology, virology and clinical features - GOV.UK

TB laboratory manuals issued to support the implementation of WHO-recommended diagnostics

ECDC and WHO publish joint surveillance bulletin on hepatitis outbreak

Vaccines against influenza: WHO position paper – May 2022

EMRG medium-term projections for COVID-19 hospitalisations and deaths: 27 April 2022 - GOV.UK

Introduction to the International Coordinating Group on Vaccine

Manual for selection of molecular WHO recommended rapid diagnostic tests for detection of tuberculosis and drug-resistant tuberculosis

Human resources for health at the Seventy-fifth World Health Assembly

WHO recommendations on malaria elimination

Coronavirus disease (COVID-19): Vaccines

Practical manual of processing stool samples for diagnosis of childhood TB

Further update on the ongoing investigation into higher than usual rates of hepatitis in children - News - Public Health Scotland

Progress Toward Polio Eradication — Worldwide, January 2020–April 2022 | MMWR

Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 11 May 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland

Global Vaccine Action Plan

WHO Director-General's live speech at 2nd Global COVID Summit – 12 May 2022

European COVID-19 reference laboratory network (ECOVID-LabNet)

European COVID-19 surveillance network (ECOVID-Net)

Monitoring reports of the effectiveness of COVID-19 vaccination - GOV.UK

National protocol for Vaxzevria COVID-19 Vaccine (ChAdOx1-S [recombinant]) - GOV.UK

Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 1 June 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland

Influenza Update N° 420

Factsheet about Marburg virus disease

ECDC and Africa CDC to share experiences in 3-day meeting on surveillance, data management and epidemic intelligence

An integrated approach to building health systems resilience | OpenWHO

Update on the ongoing investigation into higher than usual rates of hepatitis in children - News - Public Health Scotland

COVID-19 information and guidance for workplaces and community settings- version 1.1 - COVID-19 information and guidance for workplaces and community settings - Publications - Public Health Scotland

Communicable disease threats report, 1-7 May 2022, week 18

Vaccine update: issue 327, May 2022, SCID, TB and BCG special edition - GOV.UK

Influenza Update N° 418

Global excess deaths associated with COVID-19 (modelled estimates)

Methods for estimating the excess mortality associated with the COVID-19 pandemic

Coronavirus (COVID-19) testing for hospices - GOV.UK

Ultra-low temperature vaccine management | OpenWHO

WHO Director-General's opening remarks at the ninth meeting of the Working Group on Strengthening WHO Preparedness and Response to Health Emergencies – 4 May 2022

International Workshop on COVID-19 Lessons to Inform Pandemic Influenza Response: Proceedings of a Workshop

Rapid communication: Key changes to the treatment of drug-resistant tuberculosis

Avian influenza (bird flu) - GOV.UK

UKHSA data series on deaths in people with COVID-19: technical summary - GOV.UK

COVID-19 vaccination: a guide on pregnancy and breastfeeding - GOV.UK

ASPHER - Updating Core Competencies In Applied Infectious Disease Epidemiology (UCCAIDE)

Questions and answers on COVID-19: Travelling

COVID-19: epidemiological update. Weekly report. Week 16. 28 April 2022.

Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 4 May 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland

Hospital onset COVID-19 cases in Scotland - Week ending 1 March 2020 to week ending 10 April 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland

Communicable disease threats report, 24-30 April 2022, week 17

Climate Change and Health

COVID-19 vaccine uptake in healthcare workers: explainer - GOV.UK

Hepatitis of unknown origin - Reporting protocol 2022

Increase in severe acute hepatitis cases of unknown aetiology in children

Protecting workers' health and safety: Online training resources at your fingertips

A second booster could avert a substantial proportion of COVID-19 deaths between now and mid-autumn 2022 in older age groups

Public health considerations and evidence to support decisions on the implementation of a second mRNA COVID-19 vaccine booster dose

Weekly national seasonal respiratory report - Week 16 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland

STOP Program

Transitioning beyond the acute phase of the COVID-19 pandemic: Approaches and tools used by a sample of EU countries in the transition and de-escalation phase – interim report

UNICEF and WHO warn of ‘perfect storm' of conditions for measles outbreaks, affecting children

Hospital onset COVID-19 cases in Scotland - Week ending 1 March 2020 to week ending 3 April 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland

Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 27 April 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland

Multi-country outbreak of Salmonella Typhimurium linked to chocolate products – Europe and the United States of America

Assessment of point-of-care testing devices for infectious disease surveillance, prevention and control – a mapping exercise

The ACT-Accelerator: Two years of impact

Questions and answers on COVID-19: Basic facts

Sinovac CoronaVac® [Vero Cell]- Inactivated, COVID-19 vaccine

Multi-Country – Acute, severe hepatitis of unknown origin in children

Solidarity Trial Vaccines

Factsheet about Crimean-Congo haemorrhagic fever

Q&A on RTS,S malaria vaccine

Estimated number of deaths due to tuberculosis, excluding HIV

Accelerating COVID-19 Vaccine Deployment

The WHO Essential Medicines List Antibiotic Book: infographics

19 April update: Monophasic Salmonella Typhimurium outbreak

Influenza Update N° 417

WHO global conference on communicating science during health emergencies, Geneva, Switzerland, 7–25 June 2021 (‎virtual meeting)‎: meeting report

ECDC/EACS/WHO statement: Ensuring high-quality of HIV care for displaced people from Ukraine

Communicable disease threats report, 17-23 April 2022, week 16

COVID-19 vaccines and medicines: updates for April 2022 - GOV.UK

COVID-19 information and guidance for workplaces and community settings - version 1.0 - COVID-19 information and guidance for workplaces and community settings - Publications - Public Health Scotland

Go.Data

Malaria Policy Advisory Group (MPAG) meeting (March 2022)

Summary of Product Characteristics Comirnaty 30 micrograms/dose concentrate (purple cap) - GOV.UK

Consolidated report of country success stories in mitigating the impact of the COVID-19 pandemic on TB services

Hospital onset COVID-19 cases in Scotland - Week ending 1 March 2020 to week ending 27 March 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland

Hospital onset COVID-19 cases in Scotland - Week ending 1 March 2020 to week ending 20 March 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland

Acute hepatitis of unknown aetiology – the United Kingdom of Great Britain and Northern Ireland

Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 20 April 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland

Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 13 April 2022 - Repository - Public Health Scotland

Eliminate Yellow Fever Epidemics (EYE) 2017 – 2026

Report on the investigation into the origin of recent cases of hepatitis in Scotland published - News - Public Health Scotland

Societal Experts Action Network: Strategies for Communicating with People Who Are Not Vaccinated to Build Confidence in Covid-19 Vaccines | The National Academies Press

Estimated number of people (all ages) living with HIV

Vector Control Advisory Group (VCAG)

Remote health advice: weekly bulletins for 2022 - GOV.UK

Surveillance to Track Progress Toward Polio Eradication — Worldwide, 2020–2021 | MMWR

WHO Operational Handbook on Tuberculosis, Module 4: Treatment - Drug-Susceptible Tuberculosis Treatment

Environmental surveillance for SARS-COV-2 to complement public health surveillance – Interim Guidance

COVID-19 Emergency ICD Codes

Communicable disease threats report, 10-16 April 2022, week 15

Factsheet about seasonal influenza

Statement on the eleventh meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic

How to temperature map cold chain equipment and storage areas

Strategic and Technical Advisory Group on Infectious Hazards with Pandemic and Epidemic Potential (STAG-IH) Terms of reference

Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19–Associated Hospitalization Among Adults with Previous SARS-CoV-2 Infection — United States, June 2021–February 2022 | MMWR

Increase in acute hepatitis of unknown origin among children – United Kingdom

WHO Director-General's opening remarks at the Public Hearing regarding a new international instrument on pandemic preparedness and response – 12 April 2022

#ENDTB Webinar: Live Demo of WHO's End TB E-Learning Platform

World Malaria Day 2022

Increase in hepatitis (liver inflammation) cases in children under investigation - GOV.UK

Immunization, Vaccines and Biologicals

New frontiers in vector control

COVID-19 IHR Emergency Committee

WHO Director-General's opening remarks at the 11th meeting of the Emergency Committee for COVID-19 – 11 April 2022

Genuine intersectoral collaboration is needed to achieve better progress in vector control

Scientific and strategic talks on COVID-19 | OpenWHO

Reading: The Future of Nursing 2020-2030: Charting a Path to Achieve Health Equity |The National Academies Press

Health workforce: Medical doctors

COVID-19: epidemiological update. Weekly report. Week 13. 7 April 2022.

High consequence infectious diseases (HCID) - GOV.UK

WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Susceptible Tuberculosis Treatment

Malaria: The malaria vaccine implementation programme (MVIP)

Malaria

Recognising the signs - Investigating a global upsurge in severe hepatitis among young children - Our blog - Public Health Scotland

Communicable disease threats report, 3-9 April 2022, week 14

Rapid outbreak assessment: Multi-country Salmonella outbreak linked to chocolate products

WHO Webinar Series to Support Implementation of National Action Plans on Antimicrobial Resistance

Clinical care of severe acute respiratory infections – Tool kit

Video: ECDC Director on fourth doses of mRNA COVID-19 vaccines

Weekly national seasonal respiratory report - Week 12 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland

WHO records 100th attack on health care in Ukraine

Core competencies in applied disease epidemiology in Europe: facilitating collaboration and the use of a common language among professionals

COVID-19 - information and guidance for care home settings (for older adults) - COVID-19 - information and guidance for care home settings (for older adults) - Publications - Public Health Scotland

MRSA, MSSA, Gram-negative bacteraemia and CDI: quarterly report - GOV.UK

Testing for tuberculosis infection and screening for tuberculosis disease among refugees arriving in European countries from Ukraine

EFSA and ECDC investigate multi-country Salmonella outbreak linked to chocolate products

Prevalence of COVID-19 remains at high levels across the country - GOV.UK

Stakeholder consultative meeting on prevention and management of childhood pneumonia and diarrhoea: report, 12–14 October 2021

Therapeutics and COVID-19

Antibodies recognize new SARS-CoV-2 Omicron variant after booster | National Institutes of Health (NIH)

COVID-19 highest risk programme - COVID-19 data and intelligence - COVID-19 - Our areas of work - Public Health Scotland

Dengue - Annual Epidemiological Report for 2020

Strategic framework for collaboration on antimicrobial resistance

WHO announces updates on new TB antigen-based skin tests for the diagnosis of TB infection

UK COVID-19 Inquiry: draft terms of reference (HTML) - GOV.UK

Shiga toxin-producing Escherichia coli (STEC) data: 2019

WHO's response to COVID-19 - 2021 Annual Report

COVID-19: guidance for people whose immune system means they are at higher risk - GOV.UK

Suspension of supply of COVID-19 vaccine (COVAXIN®)

WHO supports regions to increase COVID-19 vaccination uptake among seniors, indigent population

What Clinicians Need to Know About Pfizer-BioNTech COVID-19 Vaccination of Adolescents

Explore the indicators

Waterbone outbreaks of hepatitis E: recognition, investigation and control: technical report

Lessons Learned from National Public Health Institutes' Response to the COVID-19 Outbreak in 2020 | IANPHI

Statement for healthcare professionals: How COVID-19 vaccines are regulated for safety and effectiveness

Operational Guide: The early warning and response systems (EWARS) for Dengue Outbreaks

WHO Policy Guidance on Integrated Antimicrobial Stewardship Activities

Global HIV, Hepatitis and STIs Programmes

Toward a National Health Care Survey: A Data System for the 21st Century |The National Academies Press

World Health Statistics

Communicable disease threats report, 15-21 May 2022, week 20

Cansino Ad5-nCoV-S vaccine recommendations for use

Strengthening collaboration on Health Technology Assessment

An Introduction to Digital Clinical Safety

Armenia to host WHO Emergency Medical Teams (EMT) Global Meeting 2022

The control of neglected zoonotic diseases: community based interventions for NZDs prevention and control

Communicating risk in public health emergencies

Antimicrobial stewardship programmes in health-care facilities in low-

Variants: distribution of case data, 1 April 2022 - GOV.UK

Estimated number of incident tuberculosis cases

Using the NHS COVID Pass to demonstrate COVID-19 status - GOV.UK

Communicable disease threats report, 27 March-2 April 2022, week 13

New WHO Global Competency Standards aim to strengthen the health workforce and support provision of quality health services to refugees and migrants

Types of drug-resistant TB

Buruli ulcer

One Health High-Level Expert Panel Annual Report 2021

Letter to malaria partners (March 2022)

No more neglect — Female genital schistosomiasis and HIV — Integrating sexual and reproductive health interventions to improve women's lives

In vitro diagnostics for COVID-19

Rapid outbreak assessment – first update: Multi-country Salmonella outbreak linked to chocolate products

Promoting the health of refugees and migrants during COVID-19 pandemic

TB monitoring and evaluation

Stronger collaboration for an equitable and resilient recovery towards the health-related Sustainable Development Goals, incentivizing collaboration

Surveillance for human infection with Middle East respiratory syndrome coronavirus (MERS - CoV)

Seventy-fifth World Health Assembly to focus on "Health for Peace, Peace for Health" for recovery and renewal

Interim statement on the use of additional booster doses of Emergency Use Listed mRNA vaccines against COVID-19

Health Workforce Support and Safeguards List

WHO Director-General's opening remarks at the COVID-19 media briefing– 17 May 2022

The humanitarian emergency settings perceived needs scale (‎HESPER)‎

Interim guideline: nutritional care of children and adults with Ebola virus disease in treatment centres: key recommendations

Nursing and midwifery personnel (per 10 000 population)

Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline

Outcome

The NHS influenza immunisation programme 2022 to 2023

Target product profile for a point-of-care diagnostic test for dermal leishmaniases

Avian influenza overview December 2021– March 2022

Q&A on Myocarditis and Covid-19 Vaccines

COVID-19: Joint statement from ECDC and EMA on the administration of a fourth dose of mRNA vaccines

Coronavirus disease (COVID-19)

COVID-19 - information and guidance for social, community and residential care settings - version 2.1 - COVID-19 - information and guidance for social, community and residential care settings - Publications - Public Health Scotland

Data on the size of the HIV/AIDS epidemic

Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 30 March 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland

Hospital onset COVID-19 cases in Scotland - Week ending 1 March 2020 to week ending 6 March 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland

Coronavirus disease (COVID-19): Children and masks

Global genomic surveillance strategy for pathogens with pandemic and epidemic potential, 2022–2032

Weekly operational update on COVID-19 - 30 March 2022

Almost 80% of eligible over-75s receive spring booster - GOV.UK

Epidemiological update on SARS-CoV-2 Omicron sub-lineages BA.4 and BA.5

Weekly national seasonal respiratory report - Week 18 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland

Line probe assays for detection of drug-resistant tuberculosis: interpretation and reporting manual for laboratory staff and clinicians

Coronavirus disease (COVID-19): Pregnancy, childbirth and the postnatal period

NHS COVID-19 app

Plague

Solidarity Trial Vaccines (STV) presentation

Coronavirus (COVID-19) Infection Survey technical article: cumulative incidence of the number of people who have tested positive for COVID-19 - GOV.UK

Cholera

Hospital onset COVID-19 cases in Scotland - Week ending 1 March 2020 to week ending 13 March 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland

Coronavirus (COVID-19) testing for adult social care services - GOV.UK

Weekly epidemiological update on COVID-19 - 29 March 2022

The European Union Summary Report on Antimicrobial Resistance in zoonotic and indicator bacteria from humans, animals and food in 2019–2020

European Union funding boosts COVID-19 vaccination in Africa

Summary of Product Characteristics for Nuvaxovid dispersion for injection - GOV.UK

Summary of Product Characteristics for Spikevax - GOV.UK

Changes to COVID-19 testing in England from 1 April - GOV.UK

Innovation at work: reflections from Malawi on the world's first malaria vaccine, RTS,S, in childhood vaccination

Tuberculosis deaths rise for the first time in more than a decade due to the COVID-19 pandemic

Pregnant women urged to come forward for COVID-19 vaccination - GOV.UK

Variants: distribution of case data, 6 May 2022

Patient Information Leaflet Comirnaty 30 micrograms/dose concentrate (purple cap) - GOV.UK

Coronavirus disease (COVID-19): Vaccines safety

EASA and ECDC take first steps to relax COVID-19 measures for air travel

COVID-19 statistical report - 11 May 2022 - COVID-19 statistical report - Publications - Public Health Scotland

Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 17 April 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland

Epidemiological update: Hepatitis of unknown aetiology in children

Health systems resilience toolkit: a WHO global public health good to support building and strengthening of sustainable health systems resilience in countries with various contexts

Increased funding for nursing in care homes - GOV.UK

Hospital onset COVID-19 cases in Scotland - Week ending 1 March 2020 to week ending 27 February 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland

COVID-19 vaccination: guide for employers - GOV.UK

Patient Information Leaflet for Spikevax - GOV.UK

Vaccine update: issue 325, April 2022, flu special edition - GOV.UK

WHO and MPP announce the first transparent, global, non-exclusive licence for a COVID-19 technology

Report of the 7th virtual end TB strategy summit for the highest TB burden countries and countries on the WHO global watchlist, 16–17 November 2021

COVID-19 variants identified in the UK - GOV.UK

Update 76 – Masks in the context of COVID-19

WHO Director-General's opening remarks press briefing in Kyiv- 7 May 2022

Strengthening COVID-19 vaccine demand and uptake in refugees and migrants

Communicable disease threats report, 20-26 March 2022, week 12

14.9 million excess deaths associated with the COVID-19 pandemic in 2020 and 2021

COVID-19 confirmed deaths in England (to 31 March 2022): report - GOV.UK

World Neglected Tropical Diseases Day

Call for expressions of interest: Expert(s) for conducting a systematic review of the evidence for the diagnostic accuracy of targeted next-generation sequencing technologies for detection of drug resistance among people diagnosed with TB

Public Health Lessons for Non-Vaccine Influenza Interventions: Looking Past COVID-19

Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine

Climate Change and Health

Influenza virus characterisation - Summary Europe, March 2022

Guiding for impact in a rapidly changing world

Tuberculosis in the time of COVID-19

Reducing the spread of respiratory infections, including COVID-19, in the workplace

Forum on Medical and Public Health Preparedness for Disasters and Emergencies: 2020 Annual Report |The National Academies Press

Handbook for clinical management of dengue

Maternal nutrition in emergencies

Therapeutics and COVID-19: living guideline

WHO Global Initiative for Emergency and Essential Surgical Care (GIEESC)

Stop attacks on health care in Ukraine

Extensively drug-resistant Shigella sonnei infections - Europe

Global Malaria Programme

Health Emergencies

Global research on coronavirus disease (COVID-19)

WHO recommends highly successful COVID-19 therapy and calls for wide geographical distribution and transparency from originator

Global tuberculosis report 2021

Over half of pregnant women have now had one or more doses of COVID-19 vaccines - GOV.UK

Weekly epidemiological update on COVID-19 - 12 April 2022

Poster: Are you and your family protected from vaccine-preventable diseases?

Weekly national seasonal respiratory report - Week ending 20 March 2022 - week 11

UKHSA calls for a renewed effort to tackle TB - GOV.UK

Presentation: Tuberculosis situation in the EU/EEA, 2020

WHO Academy

Acute hepatitis: technical briefing - GOV.UK

Tuberculosis remains one of the deadliest infectious diseases worldwide, warns new report

Tuberculosis surveillance and monitoring in Europe 2022 –2020 data

Emergency in Ukraine: external situation report #4, published 24 March 2022: reporting period: 17–23 March 2022

Mitigating the COVID-19 outbreak through global data sharing

Ethics in epidemics, emergencies and disasters: research, surveillance and patient care

Technological hazards and health risks in Ukraine

Press Release N°36/2021 COVID-19: The vaccine affords up to 100% protection against infections, hospitalization and death - ISS

Global Competency and Outcomes Framework for Universal Health Coverage

WHO Director-General's opening remarks at the WHO press conference – 23 March 2022

Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 23 March 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland

Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern

Hospital Preparedness for Epidemics

Launch of the Global Arbovirus Initiative

UKHSA review shows vaccinated less likely to have long COVID than unvaccinated - GOV.UK

Flying in the COVID-19 Era: Science-based Risk Assessments and Mitigation Strategies on the Ground and in the Air: Proceedings of a Workshop

Surveillance and disease data for disease vectors

Technical consultation session: ‘Access and benefits sharing and the WHO BioHub system'

The Pfizer BioNTech (BNT162b2) COVID-19 vaccine: What you need to know

Diagnostic testing and screening for SARS-CoV-2

Hospital onset COVID-19 cases in Scotland - Week ending 1 March 2020 to week ending 20 February 2022

Preventing and controlling outbreaks of COVID-19 in prisons and places of detention - GOV.UK

Nursing personnel (number)

Protect yourself against flu: Learn more about preventive measures

Open to all, anytime, anywhere: Free online courses bring vaccine knowledge to the global community

"We're at a critical point in the fight against malaria"

Infection prevention and control in adult social care: COVID-19 supplement

ESAC-Net Reporting Protocol 2022

Enhanced Surveillance of COVID-19 in Scotland

COVID-19 Resource Centre

To avert a learning catastrophe, schools must stay open amidst Omicron threat and beyond

Weekly operational updates on COVID-19 - 22 March 2022

Weekly epidemiological update on COVID-19 - 22 March 2022

Weekly epidemiological update on COVID-19 - 5 April 2022

Vaccination requirements and recommendations for international travellers; and malaria situation per country – 2021 edition

Pandemic influenza preparedness framework for the sharing of influenza viruses and access to vaccines and other benefits, 2nd ed

European Public Health Reference Framework (EPHRF)/Public Health Core Competences for Essential Public Health Operations: A Manual

Good practices for selecting and procuring rapid diagnostic tests for malaria

COVID-19 respiratory equipment

Weekly epidemiological update on COVID-19 - 1 March 2022

WHO implementation handbook for national action plans on antimicrobial resistance: guidance for the human health sector

Weekly epidemiological record, No 47, 2021, 96, 569–584

WHO report on surveillance of antibiotic consumption: 2016-2018 early implementation

Tuberculosis preventive treatment

Maintaining essential health services during the COVID-19 outbreak

Malaria Policy Advisory Group (MPAG) meeting (October 2021)

Global epidemiological surveillance standards for influenza

Report of the WHO global technical consultation on public health and social measures during health emergencies

An ad hoc WHO technical consultation managing the COVID-19 infodemic: call for action

International travel and health

State of the world's nursing 2020: investing in education, jobs and leadership

State of the world's nursing 2020: investing in education, jobs and leadership (Annex)

Meeting of the Strategic Advisory Group of Experts on Immunization, October 2014: conclusions and recommendations

COVAX No-Fault Compensation Program

COVID-19 vaccine country readiness and delivery

Recommendations announced for influenza vaccine composition for the 2022-2023 northern hemisphere influenza season

Behavioural considerations for acceptance and uptake of COVID-19 vaccines

WHO Advisory Committee on Variola Virus Research, 21st meeting

Definitions and reporting framework for tuberculosis

Handbook for the Management of Public Health Events in Air Transport

European External Influenza Virus Quality Assessment Programme – 2020 data

WHO treatment guidelines for drug-resistant tuberculosis, 2016 update

Communicable disease threats report, 20-26 February 2022, week 8

NAM & WHO Encourage Digital Platforms to Apply Global Principles for Identifying Credible Sources of Health Information

Hospital onset COVID-19 mortality in Scotland - 7 March 2020 to 31 December 2021

COVID-19 - information and guidance for social, community and residential care settings

Hospital onset COVID-19 cases in Scotland

Schistosomiasis

Hospital onset COVID-19 cases in Scotland - Week ending 1 March 2020 to week ending 30 January 2022

COVID-19 reporting to include further data on reinfections

COVID-19 statistical report as at 21 February 2022

Children’s vaccination rates in Scotland increased significantly during lockdown

Weekly national seasonal respiratory report - Week ending 20 February 2022 - week 7

WHO Pharmaceuticals Newsletter - N°1, 2022

Respiratory infections: laboratory reports 2022

Covid-19: Scientists and medics warn that it is too soon to lift all restrictions in England

Rapid lateral flow coronavirus (COVID-19) tests

Weekly national seasonal respiratory report - WWeek ending 13 February 2022 - week 6

Caring for those who care: guide for the development and implementation of occupational health and safety programmes for health workers: executive summary

EVA - Explore ECDC's training Catalogue 2022

Work Programme 2022 of the EU Initiative on Health Security

WHO guideline on health workforce development, attraction, recruitment and retention in rural and remote areas

Emergencies - Partners

Health workforce development, attraction, recruitment and retention in rural and remote areas

COVID-19 Resources for Members and Global Public Health Professionals

WHO SEA Regional Collaborative Framework for coordinated response to Mental Health and Psychosocial Support (‎MHPSS)‎ in emergencies

Treatment and pharmaceutical prophylaxis of COVID-19

The launch of the WHO/Europe-ASPHER Roadmap to Professionalizing the Public Health Workforce

WHO announces first technology recipients of mRNA vaccine hub with strong support from African and European partners

Communicable disease threats report, 13-19 February 2022, week 7

Coronavirus: how to stay safe and help prevent the spread

WHO announces the development of new guidance on offering long acting injectable cabotegravir as HIV prevention for people at substantial risk for HIV infection

COVID-19 vaccines

Measles outbreak training

Press Release N° 34/2021 COVID-19: in Italy the Delta variant increased in June reaching 16.8%, while the rampant variant is the English variant (74.92%)

Scientists pinpoint mechanisms associated with severe COVID-19 blood clotting

JCVI statement on vaccination of children aged 5 to 11 years old

Notes from the Field: Outbreak of COVID-19 Among a Highly Vaccinated Population Aboard a U.S. Navy Ship After a Port Visit — Reykjavik, Iceland, July 2021

COVID-19: reducing outbreak risk with repeated antigen screening in healthcare facilities

STD Awareness Week - General Resources

Public health surveillance for COVID-19: interim guidance

R&D Blueprint

Self-Study Modules on Tuberculosis

Innovative genomic data analysis method leads to the discovery of novel coronavirus families

Enhanced Surveillance of COVID-19 in Scotland - 02 March 2022

Enhanced Surveillance of COVID-19 in Scotland - 16 March 2022

UK scales back routine covid-19 surveillance

Vaccine Safety Basics

UKRAINE | Online courses in Ukrainian support national response to the COVID-19 pandemic and other emergencies

Malaria vaccine: WHO position paper – March 2022

The role of Europe’s Schools of Public Health in times of war: ASPHER statement on the war against Ukraine

Communicable disease threats report, 27 February - 5 March 2022, week 9

Healthier, fairer, safer: the global health journey 2007–2017

Impact of the COVID-19 pandemic on seven neglected tropical diseases: a model-based analysis

Weekly national seasonal respiratory report - Week ending 27 February 2022 - week 8

Infographic: Total antibiotic consumption in humans

Infographic: Consumption of antibiotics in humans and food-producing animals, EU/EEA 2014-2018

WHO updates its treatment guidelines to include molnupiravir

About the NHS Health Check elearning programme

Transmission of SARS-CoV-2 from mother to baby is rare, say researchers

Safety in administering medicines for neglected tropical diseases

Weekly national seasonal respiratory report- Week ending 13 March 2022 - week 10

Covid-19: Doctors urge government to step up on global vaccine funding

Information for UK recipients on Pfizer/BioNTech COVID-19 vaccine (Regulation 174)

Communicable disease threats report, 13-19 March 2022, week 11

WHO Director-General's remarks at United Nations Security Council meeting on Ukraine – 17 March 2022

Operational public health considerations for the prevention and control of infectious diseases in the context of Russia’s aggression towards Ukraine

Prevention and control of infectious diseases in the context of Russia’s aggression towards Ukraine

COVID-19 vaccination programme for children and young people: guidance for parents (version 3)

Mental health in emergencies

COVID-19 vaccine information and resources

WHO released a new operational guide to promote COVID-19 vaccination uptake and tackle vaccine hesitancy among refugees and migrants

Global Health Emergency Appeal 2022

Global Malaria Programme

Global State of PrEP

Guidelines on the public health response to pretreatment HIV drug resistance

Oral Sex and HIV Risk

Evusheld approved to prevent COVID-19 in people whose immune response is poor

COVID-19 testing, vaccination and implementation of protective measures recommended for reception centres of displaced people from Ukraine

True extent of SARS-CoV-2 Infection through seroprevalence studies

Global Advisory Committee on Vaccine Safety (GACVS) review of latest evidence of rare adverse blood coagulation events with AstraZeneca COVID-19 Vaccine (Vaxzevria and Covishield)

Preferred Product Characteristics for Personal Protective Equipment for the Health Worker on the Frontline Responding to Viral Hemorrhagic Fevers in Tropical Climates

Prime Minister sets out plan for living with COVID

The R value and growth rate

Coronavirus (COVID-19) test kits for children's homes

COVID-19 content collection

Executive summary ‒ Ending the neglect to attain the sustainable development goals. One health: approach for action against neglected tropical diseases 2021‒2030

Malaria rapid diagnostic test performance. Results of WHO product testing of malaria RDTs: Round 8 (2016-2018)

Guidelines for prevention and control of Chikungunya fever

Polio vaccines: WHO position paper – March 2016

Weekly epidemiological update on COVID-19 - 8 March 2022

Influenza virus characterisation - Summary Europe, February 2022

Glossary of Health Emergency and Disaster Risk Management Terminology

Report of the Third Meeting of the WHO Onchocerciasis Technical Advisory Subgroup Geneva, Switzerland, 26‒28 February 2019

Global technical strategy for malaria 2016–2030

Improving the quality of health services: tools and resources

Second meeting of the WHO diagnostic technical advisory group for neglected tropical diseases, 13 October 2020

World malaria report 2018

Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™)

WHO guidelines for the prevention of sexual transmission of Zika virus

Strategic planning for implementation of the health-related articles of the Minamata Convention on Mercury

Statement on Omicron sublineage BA.2

WHO Director-General's remarks at the 4th Meeting of Global Leaders Group on AMR – 16 March 2022

Ukraine: migrant health guide

COVID-19 statistical report - As at 15 March 2022

Interim statement of the COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety on AstraZeneca COVID-19 vaccine

Workshop on the challenges when setting up Public Health and Emergency Operation Centres

Coronavirus disease (COVID-19): Ventilation and air conditioning

Weekly national seasonal respiratory report - Week ending 6 March 2022 - week 9

Coronavirus vaccine - weekly summary of Yellow Card reporting

COVID-19 advice for the public: Getting vaccinated

National flu and COVID-19 surveillance reports published

Statement by NAM President Victor Dzau on Responding to the Health Crisis In and Around Ukraine

Communicable disease threats report, 6-11 March 2022, week 10

ASPHER statement marking two years of the COVID-19 pandemic

Essential public health functions, health systems and health security

All COVID-19 travel restrictions removed in the UK

Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks: Proceedings of a Workshop

Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative

Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines

Strengthening COVID-19 vaccine demand and uptake in refugees and migrants

Webinars on COVID-19

Infographics, posters and leaflets about COVID-19

Effective teaching: a guide for educating healthcare providers

Eighth Meeting of the Multilateral Leaders Task Force on COVID-19, 1 March 2022: "Third Consultation with the CEOs of leading vaccine manufacturers"

WHO technical brief for countries preparing malaria funding requests for the Global Fund (2020–2022)

Download COVID-19 datasets

COVID-19 vaccination

Guidance for the prevention and control of COVID-19 in temporary reception centres in the context of the large numbers of people fleeing Ukraine

WHO guideline on control and elimination of human schistosomiasis

WHO advises that ivermectin only be used to treat COVID-19 within clinical trials

Twelfth meeting of the WHO Vector Control Advisory Group

SARS-CoV-2 variants dashboard

Assessing Meaningful Community Engagement: A Conceptual Model to Advance Health Equity through Transformed Systems for Health

Evaluation of the SARS-CoV-2 testing policy in Belgium from June to December 2021

Infection

WHO consultation on COVID-19 vaccines research - Advancing the development of pan-sarbecovirus vaccines

What is PHC?

Launch of the WHO implementation handbook for national action plans on AMR

A WHO Strategic Agenda for Filovirus Research and Monitoring (AFIRM) - Roadmap Meeting

Data collection on COVID-19 outbreaks in closed settings: long-term care facilities, version 2.1

WHO Open Calls for Advisory Groups

WHO PrEP Implementation Tool

A checklist for pandemic influenza risk and impact management: building capacity for pandemic response

Covid-19: Evusheld is approved in UK for prophylaxis in immunocompromised people

Ukrainians fleeing war granted free access to NHS healthcare

Measles Lab Manual from the World Health Organization

Tracking SARS-CoV-2 variants

Guidance for people previously considered clinically extremely vulnerable from COVID-19

COVID-19 statistical report as at 28 February 2022

Everyone’s business: Whole-of-society action to manage health risks and reduce socio-economic impacts of emergencies and disasters: Operational guidance

Coronavirus disease (COVID-19): Masks

WHO policy guidance on integrated antimicrobial stewardship activities

COVID-19: track coronavirus cases

WHO Outbreak Toolkit

Coronavirus disease (COVID-19) Weekly Epidemiological Update and Weekly Operational Update

Weekly epidemiological update on COVID-19 - 15 March 2022

Weekly operational update on COVID-19 - 15 March 2022

Videos on COVID-19

The Global Health Observatory

Categoria Argomento




Categoria Profilo




Categoria Lingua




Categoria Tipologia




Categoria Paese